脂質栄養学 ―「日本人の健康と脂質」の理解を求めて―

出版社： 幸書房
著者：
発行日： 2016-04-05
分野： 臨床医学：一般  >  栄養/食事/輸血
ISBN： 9784782104088
電子書籍版： 2016-04-05 （初版第1刷）
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,970 円(税込)

購入する

商品紹介

本書の目的は、「脂質の摂取と健康」との関係をひも解くことにある。本書では、健康と係わりが深い脂質（油脂）成分の栄養問題を科学的のみならず学問的に中立的な立場から理解するため、出来るだけ多くの情報を解りやすく解説することで読者の判断を容易にするよう努めた。本書は、研究者だけでなく、栄養指導に係わる管理栄養士の皆さんにも広く利用して頂きたい。

目次

  • 表紙
  • 序文
  • 目次
  • はじめに 脂質栄養学における食品栄養学的な考え方
  • 第1章 脂質栄養を理解するための基礎知識
  • 1.1 用語の問題
  • 1.2 食品中の脂肪酸
  • 1.3 食用油脂
  • 1.3.1 植物油脂
  • 1.3.2 動物油脂
  • 1.3.3 食用油脂消費の現状
  • 1.3.4 トリグリセリド構造 ( 構造脂質 )
  • 1.3.5 脂肪酸以外の成分
  • 1.3.6 油脂の特数
  • 第2章 脂肪の消化と吸収
  • 2.1 消化・吸収機構
  • 2.2 吸収された脂肪の動き
  • 2.3 中鎖脂肪酸の吸収機構
  • 2.4 難消化性油脂
  • 第3章 脂質の栄養機能
  • 3.1 栄養機能の概要
  • 3.1.1 エネルギー価
  • 3.1.2 必須脂肪酸の給源
  • 3.1.3 脂溶性成分の給源と吸収促進作用
  • 3.2 油脂と味覚
  • 第4章 脂質の生理機能
  • 4.1 飽和脂肪酸
  • 4.1.1 飽和脂肪酸リスク説の背景
  • 4.1.2 飽和脂肪酸リスク説への反論
  • 4.1.3 飽和脂肪酸無罪論の展開
  • 4.1.4 飽和脂肪酸問題の決着
  • 4.1.5 パーム油は危険な油か
  • 4.1.6 パルミチン酸以外の飽和脂肪酸の影響
  • 4.1.7 食品業界の対応 : 加工肉製品での脂肪置換
  • 4.1.8 まとめ
  • 4.2 一価不飽和脂肪酸 ( モノ不飽和脂肪酸 )
  • 4.2.1 オレイン酸の有用性
  • 4.2.2 オレイン酸は「静かな脂肪酸」
  • 4.2.3 静かな脂肪酸説への反論
  • 4.2.4 オレイン酸以外の一価不飽和脂肪酸
  • 4.2.5 まとめ
  • 4.3 多価不飽和脂肪酸
  • 4.3.1 必須脂肪酸としての多価不飽和脂肪酸
  • 4.3.2 n - 6系脂肪酸と心疾患
  • 4.3.3 n - 3系脂肪酸と心疾患
  • 4.3.4 n - 6 / n - 3比問題
  • 4.3.5 必須脂肪酸の代謝
  • 4.3.6 多価不飽和脂肪酸の比較生理機能論
  • 4.3.7 アラキドン酸の機能
  • 4.3.8 血液濃度からの多価不飽和脂肪酸摂取量の評価
  • 4.3.9 オメガ3製品 ( サプリメント ) についての理解
  • 4.3.10 まとめ
  • 4.3.11 多価不飽和脂肪酸と冠動脈心疾患 : 総括
  • 4.4 トランス脂肪酸
  • 4.4.1 トランス脂肪酸とは
  • 4.4.2 トランス脂肪酸と冠動脈心疾患のリスク
  • 4.4.3 リノール酸によるトランス脂肪酸のリスク低減
  • 4.4.4 トランス脂肪酸が心疾患リスクを高めるメカニズム
  • 4.4.5 閾値あるいは許容上限量の問題
  • 4.4.6 どのトランス異性体に責任があるのか
  • 4.4.7 天然型トランス脂肪酸擁護論
  • 4.4.8 トランス脂肪酸規制策
  • 4.4.9 トランス脂肪酸規制の効果
  • 4.4.10 わが国での現状と対応状況
  • 4.4.11 トランス脂肪酸問題の今後
  • 4.4.12 まとめ
  • 4.5 中鎖脂肪酸 ( medium - chain fatty acid )
  • 4.5.1 中鎖脂肪酸と中鎖脂肪 ( medium - chain triglyceride, MCT )
  • 4.5.2 中鎖脂肪酸の消化吸収
  • 4.5.3 中鎖脂肪酸のβ酸化とケトン体の生成
  • 4.5.4 MCT・MLCTに期待される生理的機能
  • 4.5.5 まとめ
  • 4.6 短鎖脂肪酸 ( short chain fatty acid, SCFA )
  • 第5章 油脂と肥満
  • 5.1 嫌われる「あぶら」
  • 5.2 肥満を巡るわが国の現状
  • 5.3 「あぶら」を食べると本当に肥るのか
  • 5.3.1 現状理解
  • 5.3.2 高炭水化物食 ( 低脂肪食 ) で体重は増加する
  • 5.4 「脂肪の摂取と肥満との関係」の理解
  • 5.5 すべての油脂が同様な効果を示すか ?
  • 5.6 わが国における状況
  • 5.7 肥満の遺伝子メカニズム : 脂肪酸のβ酸化との関連性
  • 5.8 褐色脂肪組織
  • 5.9 異所性脂肪
  • 5.10 脂肪酸のβ酸化の熱力学
  • 5.11 食事脂肪と肥満を巡る現状
  • 5.12 まとめ
  • 第6章 コレステロールの栄養学
  • 6.1 食品中のコレステロール含有量と摂取源
  • 6.2 コレステロール代謝 : 吸収
  • 6.3 コレステロール代謝 : 体内合成・異化・排泄
  • 6.4 血液コレステロール濃度と心疾患リスク
  • 6.4.1 コレステロールの摂取と血清コレステロール濃度
  • 6.4.2 食事脂肪と血清コレステロール濃度
  • 6.4.3 血液コレステロール濃度と癌
  • 6.5 酸化コレステロール
  • 6.5.1 コレステロールの自動酸化
  • 6.5.2 生体内で生成した酸化コレステロール
  • 6.6 まとめ
  • 第7章 植物ステロールの栄養学
  • 7.1 植物ステロール・植物スタノール
  • 7.2 植物ステロールの種類と存在
  • 7.3 植物ステロール・スタノールの降コレステロール作用とその特性
  • 7.4 コレステロール吸収阻害機構と植物ステロールの吸収
  • 7.4.1 植物ステロールのコレステロール吸収阻害機構
  • 7.4.2 植物ステロールの吸収
  • 7.5 その他の機能
  • 7.6 植物ステロール酸化物
  • 7.7 植物ステロールの有効利用
  • 7.8 まとめ
  • 第8章 脂質の食事摂取基準
  • 8.1 食事摂取基準の基本理念と特徴
  • 8.2 食事摂取基準2015年版
  • 8.2.1 脂質の総エネルギーに占める割合 ( 脂肪エネルギー比率 )
  • 8.2.2 飽和脂肪酸
  • 8.2.3 n - 6系脂肪酸
  • 8.2.4 n - 3系脂肪酸
  • 8.2.5 その他の脂肪酸
  • 8.2.6 コレステロール
  • 8.2.7 生活習慣病の重症化予防
  • 8.3 脂質栄養学の真髄
  • 第9章 食用油脂の安全性を巡って
  • 9.1 油脂の精製中に生成する健康リスク成分
  • 9.1.1 MCPDとグリシドール
  • 9.1.2 トランス脂肪酸
  • 9.2 油脂を用いる加熱加工・調理に伴い生成する成分
  • 9.2.1 還元糖との反応で生成するアクリルアミド
  • 9.2.2 加熱に伴う過酸化脂質
  • 9.3 まとめ
  • 第10章 脂質と健康 : 新しい情報を中心に
  • 10.1 歴史的背景と現実
  • 10.2 地中海型食事とオレイン酸の効用
  • 10.3 n - 3系長鎖多価不飽和脂肪酸を巡る議論
  • 10.4 肥満との関係 - 食事脂肪低減化の問題点
  • 10.5 食事脂肪とリポタンパク質代謝
  • 10.6 脂肪酸の供給源としての植物油
  • 10.7 食事脂肪と腸内細菌 : 炎症, バリアー機能および代謝的効果
  • 10.8 まとめ
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

はじめに 脂質栄養学における食品栄養学的な考え方

P.2 掲載の参考文献
1) Nestle M, Eating made simple. Scientific American, 297 : 60-69 (2007)
PubMed

第1章 脂質栄養を理解するための基礎知識

P.18 掲載の参考文献
1) Liu KS, Soy oil modification : products, applications. Inform, 10 : 868-875 (1999)
 
2) Lichtenstein AH, Matthan NR, Jalbert SM et al., Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am. J. Clin. Nutr., 84 : 497-504 (2006)
PubMed
3) Banz WJ, Davis JE, Clough RW et al., Stearidonic acid : is there a role in the prevention and management of type 2 diabetes mellitus? J. Nutr., 142 : 635S-640S (2012)
 
4) Pande G, Akoh CC, Shewfelt RL, Production of trans-free margarine with stearidonic acid soybean and high-stearate soybean oils-based structured lipid. J. Food Sci., 77 : C1203-C1210 (2012)
PubMed
5) Rigby NM, Sancho AI, Salt LJ et al., Quantification and partial characterization of the residual protein in fully and partially refined commercial soybean oils. J. Agric. Food Chem., 59 : 1752-1759 (2011)
PubMed
6) 菅野道廣, 大豆油はアレルギー反応を引き起こすか? 日本栄養・食糧学会誌, 59 : 313-321 (2006)
Medical*Online
7) Bockisch M, Fats and Oils Handbook, AOCS Press (1993)
 
8) Abedi E, Sahari MA, Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties. Food Sci. Nutr., 2 : 443-463 (2014)
PubMed
9) 古場一哲, 共役リノール酸 (CLA) の生理機能と食品への応用. オレオサイエンス, 10 : 415-422 (2010)
 
10) Derakhshande-Rishehri S-M, Mansourian M, Kelishadi R et al., Association of foods enriched in conjugated linoleic acid (CLA) and CLA supplements with lipid profile in human studies : a systematic review and meta-analysis. Public Health Nutr., 18 : 2041-2054 (2015)
PubMed
11) Moon H-S, Biological effects of conjugated linoleic acid on obesity-related cancers. Chem. Biol. Interact., 224C : 189-195 (2014)
 
12) Wang T, Lee HG, Advances in research on cis-9, trans-11 conjugated linoleic acid : a major functional conjugated linoleic acid. Crit. Rev. Sci. Food Nutr., 55 : 720-731 (2015)
 
13) Gangidi RR, Lokesh BR, Conjugated linoleic acid (CLA) formation in edible oils by photoisomerization : a review. J. Food Sci., 75 : R781-R785 (2014)
 
14) Gorissen L, Leroy F, De Vuyst L et al., Bacterial production of conjugated linoleic and linolenic acid in foods : a technological challenge. Crit. Rev. Food Sci. Nutr., 55 : 1561-1574 (2015)
 
15) Koba K, Belury MA, Sugano M, Potential health benefits of conjugated trienoic acids. Lipid Technol., 19 : 200-203 (2007)
 
16) Hennessy AA, Ross RP, Devery R et al., The health promoting properties of the conjugated isomers of α-linolenic acid. Lipids, 46 : 105-119 (2011)
 
17) Yuan GF, Chen XE, Li D, Conjugated linolenic acids and their bioactivities : a review. Food Funct., 5 : 1360-1368 (2014)
PubMed
18) Tuner TD, Meadus WJ, Mapiye C et al., Isolation of α-linolenic acid biohydrogenation products by combined silver ion solid phase extraction and semi- preparative high performance liquid chromatography. J. Chromatog. B, 980 : 34-40 (2015)
 
19) Houtsmuller UMT, Columbinic acid, a new type of essential fatty acid. Prog. Lipid Res., 20 : 889-896 (1981)
 
20) No DS, Kim I-H, Pinolenic acid as a new source of phyto-polyunsaturated fatty acid. Lipid Technol., 25 : 135-138 (2013)
 
21) Maki KC, Lawless AL, Kelley KM et al., Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol : results from a randomized controlled feeding trial. J. Clin. Lipidol., 9 : 49-57 (2015)
 
22) 戸谷洋一郎監修, 油脂の特性と応用, 幸書房 (2012)
 
23) 和田俊監修 : 日本水産油脂協会編, 食品中のn-3系・n-6系脂肪酸-新しいNMR分析技術を応用して-, 日本学会事務センター (2003)
 
24) De Greyt WFJ, Current and future technology for the sustainable and cost-efficient production by high quality food oils. Eur. J. Lipid Sci. Technol., 114 : 1126-1139 (2012)
 
25) Innis SM, Dietary triacylglycerol structure and its role in infant nutrition. Adv. Nutr., 2 : 275-283 (2011)
PubMed
26) Carta G, Murru E, Lisal S et al., Dietary triacylglycerols with palmitic acid in the sn-2 position modulate levels of N-acylethanolamides in rat tissues. PLoS ONE, 10 (3) : e0120424 (2015). doi : 10.1371/journal.pone.0120424
 
27) Kasai M, Nosaka N, Maki H et al., Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pacific J. Clin. Nutr., 12 :151-160 (2003)
 
28) 原健次, 生理活性脂質 ストラクチャード・トリグリセリドの生化学と応用, 幸書房 (2005)
 
29) 日本油化学会編, 油脂・脂質の基礎と応用-栄養・健康から工業まで- (2005)
 
30) Rong Y, Chen L, Tingting Zhu et al., Egg consumption and risk of coronary heart disease and stroke : dose-response meta-analysis of prospective cohort studies. BMJ, 346 : e8539 (2013)
PubMed

第2章 脂肪の消化と吸収

P.25 掲載の参考文献
1) Abumrad NA, Davidson ND, Role of the gut in lipid homeostasis. Physiol. Rev., 92 : 1061-1085 (2012)
 
2) Pan X, Mahmood Hussain M, Gut triglyceride production. Biochim. Biophys. Acta, 1821 : 727-735 (2012)
 
3) Lindquist S, Hernell O, Lipid digestion and absorption in early life : an update. Curr. Opin. Clin. Nutr. Metab. Care, 13 : 314-320 (2010)
PubMed
4) Ikeda I, Tomari Y, Sugano M et al., Lymphatic absorption of structured glycerolipids containing medium-chain fatty acids and linoleic acid, and their effect on cholesterol absorption. Lipids, 26 : 369-373 (1991)
PubMed
5) Yagi T, Yasuda F, Fushimi N et al., Lymphatic absorption of structured triacylglycerols, 1 (3) -stearoyl-2,3 (1) -dilinoleoylglycerol and 2-linoleoyl-1,3-distearoylglycerol in rats. J. Nutr. Sci. Vitaminol., 50 : 446-448 (2004)
PubMed

第3章 脂質の栄養機能

P.33 掲載の参考文献
1) Choque B, Gatheline D, Delphlanque B et al., Dietary linoleic acid requirements in the presence of α-linolenic acid are lower than the historical 2% of energy intake value, study in rats. Br. J. Nutr., 113 : 1056-1068 (2015)
 
2) Spector AA, Kim H-Y, Discovery of essential fatty acids. J. Lipid Res., 56 : 11-21 (2015)
PubMed
3) Elmadfa I, Kornsteiner M, Fats and fatty acid requirements for adults. Ann. Nutr. Metab., 55 : 56-75 (2009)
PubMed
4) Takeda S, Kimura M, Marushima R et al., Mayonnaise contributes to increasing postprandial serum α-carotene concentration through the emulsifying property of egg yolk in rats and humans. J. Nutr. Sci. Vitaminol., 57 : 209-215 (2011)
 
5) Kim JE, Gordon SL, Ferruzzi MG et al., Effects of egg consumption on carotenoid absorption from co-consumed, raw vegetables. Am. J. Clin. Nutr., 102:75-83 (2015)
PubMed
6) Goltz SR, Campbell WW, Chitchumroonchokchai C et al., Meal triacylglycerol profile modulates postprandial absorption of carotenoids in humans. Mol. Nutr. Food Res., 56 : 866-877 (2012)
PubMed
7) Pepino MY, Love-Gregory L, Klein S et al., The fatty acid translocase gene CD36 and lingual lipase inauence oral sensitivity to fat in obese subjects. J. Lipid Res., 53 : 561-566 (2012)
PubMed
8) Running CA, Mattes RD, Humans are more sensitive to the taste of linoleic and α-linolenic than oleic acid. Am. J. Physiol. Gastrointest. Liver Physiol., 308 : G442-G449 (2015)
 
9) 伏木亨, 油脂とおいしさ, 化学と生物, 45 : 486-494 (2007)
 
10) Passilly-Degrace P, Chevrot M, Bernard A et al., Is the taste of fat regulated? Biochimie, 96 : 3-7 (2014)
PubMed
11) Newman L, Haryono R, Keast R, Functionality of fatty acid chemoreception : a potential factor in the development of obesity? Nutrients, 5 : 1287-1300 (2013)
PubMed
12) Tucker RM, Mattes RD, Running CA, Mechanisms and effects of "fat taste" in human. BioFactors, 40 : 313-326 (2014)
PubMed
13) Keast RSJ, Costanzo A, Is fat the sixth taste primary? Evidence and implications. Flavour, 4 : 5 (2015)
 
14) Running CA, Craig BA, Mattes RD, Oleogustus : the unique taste of fat. Chem. Senses., 40 : 507-516 (2015)
PubMed
15) Miyamura N, Jo S, Kuroda M et al., Flavour improvement of reduced-fat peanut butter by addition of kokumi peptide, γ-glutamyl-valyl-glycine. Flavour, 4 : 16 (2015)
 

第4章 脂質の生理機能

P.141 掲載の参考文献
1) Willett WC, Dietary fats and coronary heart disease. J. Intern. Med., 272 : 13-24 (2012)
PubMed
2) Mensink RP, Zock PL, Kester ADM et al., Effects of dietar y fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins : a meta-analysis of 60 controlled trials. Am J. Clin. Nutr., 77 : 1146-1155 (2003)
 
3) 石川俊次, 野口律奈, 食事飽和脂肪酸・コレステロールと動脈硬化-最近の考え方. オレオサイエンス, 12 : 99-105 (2012)
 
4) Skeaff CM, Miller J, Dietary fat and coronary heart disease : summary of evidenced from prospective cohort and randomized controlled trials. Ann. Nutr. Metab., 55 : 173-201 (2009)
 
5) Siri-Tarino PW, Sun Q, Hu FB et al., Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr., 91 : 535-546 (2010)
PubMed
6) Micha R, Mozaffarian D, Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes : a fresh look at the evidence. Lipids, 45 :893-925 (2010)
 
7) Mozaffarian D, Micha R, Wallace S, Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat : a systematic review and meta-analysis of randomized controlled trials. PLoS Med., 7 : e1000252 (2010)
PubMed
8) Mente A, de Koning L, Shannon HS et al., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med., 169 : 659-669 (2009)
PubMed
9) Yamagishi K, Iso H, Yatsuya H et al., Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese : the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. Am. J. Clin. Nutr., 92 : 759-765 (2010)
PubMed
10) Yamagishi K, Iso H, Kokubo Y et al., Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities : the JPHC Study. Eur. Heart J., 34 : 1225-1232 (2013)
PubMed
11) Yamagishi K, Iso H, Tsugane S, Saturated fat intake and cardiovascular disease in Japanese population. J. Atheroscler. Thromb., 22 : 435-439 (2015)
PubMed
12) Rosch PJ, Genes and stress cause coronary atherosclerosis not saturated fat. Lancet, 375 : 1780-1781, author reply 1781 (2010)
 
13) Siri-Tarino PW, Sun Q, Hu FB et al., Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr., 91 : 502-509 (2010)
PubMed
14) Hite AH, Feinman RD, Guzman GE et al., In the face of contradictory evidence : report of the Dietary Guidelines for Americans Committee., Nutrition, 26 : 915-924 (2010)
PubMed
15) Hite AH, Is the science behind the 2010 Dietary Guidelines for Americans "unquestioned?" Nutrition, 27 : 385-386 (2011)
PubMed
16) Hoenselaar R, Saturated fat and cardiovascular disease : the discrepancy between scientific literature and dietary advice. Nutrition, 28 : 118-123 (2012)
PubMed
17) USDA, Scientific Report of the 2015 Dietary Guidelines Advisory Committee, Feburary 2015
 
18) Teicholz N, The scientific report guiding the US dietary guidelines : is it scientific? BMJ, 351 : h4962 (2015)
PubMed
19) Archer E, Pavela G, Lavie CJ, The inadmissibility of what we eat in America and NHANES dietary data in nutrition and obesity research and the scientific formulation of national dietary guidelines. Mayo Clin. Proc., 90 : 911-926 (2015)
PubMed
20) Astrup A, Dyerberg J, Elwood P et al., The role of reducing intakes of saturated fat in the prevention of cardiovascular disease : where does the evidence stand in 2010? Am. J. Clin. Nutr., 93 : 684-688 (2011)
PubMed
21) 厚生労働省「日本人の食事摂取基準」策定委員会報告書, 日本人の食事摂取基準, 2015年版, 第一出版 (2014)
 
22) Hooper L, Summerbell CD, Thompson R et al., Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev., 2012 May 16; 5 : CD002137. doi : 10.1002/14651858. CD002137. pub3.
 
23) Hooper L, Martin N, Abdelhamid A et al., Reduction of saturated fat intake for cardiovascular disease. Cochrane Database Syst. Rev., 2015 Jun 10 ; 6 : CD011737
 
24) Toda N, Maruyama C, Koba S et al., Japanese dietary lifestyle and cardiovascular disease. J. Atheroscler. Thromb., 18 : 723-734 (2011)
 
25) Szajewska H, Szajewski T, Saturated fat controversy : importance of systematic reviews and metaanalysis. Crit. Rev. Food Sci. Nutr., 2015 Mar 12 : 0
 
26) Bier DM, Saturated fats and cardiovascular disease : interpretations not as simple as they once were. Crit. Rev. Food Sci. Nutr., 2015 Mar 16 : 0
PubMed
27) Fattore E, Bosetti C, Brighenti F et al., Palm oil and blood lipid-related markers of cardiovascular disease : a systematic review and meta-analysis of dietary intervention trials. Am. J. Clin. Nutr., 99 : 1331-1350 (2014)
PubMed
28) Odia OJ, Ofori S, Maduka O, Palm oil and heart : a review. World J. Cardiol., 7 (3) : 144-149 (2015)
 
29) Bester D, Esterhuyse AJ, Truter EJ et al., Cardiovascular effects of edible oils : a comparison between four popular edible oils. Nutr. Res. Rev., 23 : 334-348 (2010)
PubMed
30) Hays KV, Pronczuk A, Replacing trans fat : the augment for palm oil with a cautionary note on interesterification. J. Am. Coll. Nutr., 29 : 253S-284S (2010)
 
31) Fattore E, Fanelli R, Palm oil and palmitic acid : a review on cardiovascular effects and carcinogenicity. Int. J. Food Sci. Nutr., 64 ; 648-659 (2013)
PubMed
32) Chen BK, Seligman B, Farquhar JW et al., Multi-country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development : 1980-1997. Globalization and Health, 7 : 45 (2011)
PubMed
33) Lawrence GD, Dietary fats and health : dietary recommendation in the context of scientific evidence. Adv. Nutr., 4 : 294-302 (2013)
PubMed
34) Kris-Etherton PM, Griel AE, Psota TL et al., Dietary stearic acid and risk of cardiovascular disease : intake, sources, digestion, and absorption. Lipids, 40 : 1193-1200 (2005)
PubMed
35) Karupaiah T, Tan CH, Chinna K et al., The chain length of dietary saturated fatty acids affects human postpandial lipemia. J. Am. Coll. Nutr., 30 : 511-521 (2011)
 
36) Masson CJ, Mensink R, Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postpandial lipemia and markers of inaammation and endothelial activity in overweight men. J. Nutr., 141 : 816-821 (2011)
 
37) Lacroix S, Des Rosiers C, Gayda M et al., Impact of a single mixed Mediterranean-type meal relative to a high-fat meal on metabolic markers and postprandial endothelial function. Can. J. Cardiol., 27 : S174-S175 (2012)
 
38) Malik VS, Chiuve SE, Campos H et al., Circulating very-long chain saturated fatty acids and incident coronary heart disease in U.S. men and women. Circulation, 132 : 260-268 (2015)
PubMed
39) 佐藤清隆, 油の美味しさと飽和脂肪酸. オレオサイエンス, 12 : 424 (2012)
 
40) Ospina-E JC, Sierra-C A, Ochoa O et al., Substitution of saturated fat in processed meat products : a review. Crit. Rev. Food Sci. Nutr., 52 : 113-122 (2012)
PubMed
41) Kromhout D, Geleijnse JM, Menotti A et al., The confusion about dietary fatty acids recommendations for CHD prevention. Brit. J. Nutr., 106 : 627-632 (2011)
PubMed
42) O'Flaherty M, Flores-Mateo G, Nnoaham K et al., Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull. World Health Organ., 90 : 522-531 (2012)
PubMed
43) Kuklina EV, Carroll MD, Shaw KM et al., Trends in high LDL cholesterol, cholesterol-lowering medication use, and dietary saturated-fat intake : United States, 1976-2010. National Center for Health Statistics (NCHS) Data Brief No.117 : 1-8 March 2013
 
44) Jenkins DJ, Jones PJ, Lamarche B et al., Effect of dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia : a randomized controlled trial. JAMA, 306 : 831-839 (2011)
PubMed
45) Muskiet FAJ, Muskiet MHA, Should dietary SFA exchanged for linoleic acid? Am. J. Clin. Nutr., 96 : 944-945 (2012)
PubMed
46) Khosla P, Hayes KC, Saturated fat and lipidemia : importance of study design and triglyceride structure. Am. J. Clin. Nutr., 96 : 216-218 (2012)
PubMed
47) O'Sullivan TA, Hafekost K, Mitrou F et al., Food sources of saturated fat and the association with mortality : a meta-analysis. Am. J. Public Health, 103 : e31-e42 (2013)
PubMed
48) Truswell AS, Choudhury N, Monounsaturated oils do not all have the same effect on plasma cholesterol. Eur. J. Clin. Nutr., 52 : 312-315 (1998)
PubMed
49) Waterman E, Lockwood B, Active components and clinical applications of olive oil. Altern. Med. Rev., 12 : 331-342 (2007)
PubMed
50) Ranalli F, Ranalli A, Contento S et al., Bioactives and nutraceutical phytochemicals naturally occurring in virgin olive oil. The case study of the Nocellara de Belice Italian olive cultivar. Nat. Prod. Res., 27 : 1686-1690 (2013)
 
51) Karkoula E, Melliou E, Magiatis P, A new method for the estimation of olive oil healthfulness. Inform, 24 : 266-270 (2013)
 
52) Estruch R, Ros E, Salas-Salvado J et al., Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med., 368 : 1279-1290 (2013)
 
53) Ford PA, Jaceldo-Siegl K, Lee JW et al., Intake of Mediterranean foods associated with positive affect and low negative affect. J. Psychosomatic Res., 74 : 142-148 (2013)
 
54) Brown ML, Shelness GS, Rudel LL, Monounsaturated fatty acids and atherosclerosis : opposing view from epidemiology and experimental animal models. Curr. Atheroscler. Rep., 9 : 494-500 (2007)
 
55) Jakobsen MU, O'Reilly EJ, Heitmann BL et al., Major types of dietary fat and risk of coronary heart disease : a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr., 89 : 1425-1432 (2009)
PubMed
56) Degirolamo C, Rudel LL, Dietary monounsaturated fatty acids appear not to provide cardioprotection. Curr. Atheroscler. Rep., 12 : 391-396 (2010)
PubMed
57) Rudel LL, MUFA-Mediterraneans love olive oil, but is it our friend or foe? J. Clin. Lipidol., 6 : 221-223 (2012)
 
58) Baum J, Kris-Etherton PM, Willett WC et al., Fatty acids in cardiovascular health and disease : a comprehensive update. J. Clin. Lipidol., 6 : 216-234 (2012)
 
59) Gillingham LG, Harris-Janz S, Jones PJ, Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids, 46 : 209-228 (2011)
PubMed
60) Sola R, Fito M, Estruch R et al., Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio : a randomized, controlled trial. Atherosclerosis, 218 : 174-180 (2011)
PubMed
61) Schwingshakl L, Strasser B, Hoffmann G, Effects of monounsaturated fatty acids on cardiovascular risk factors : a systematic review and meta-analysis. Ann. Nutr. Metab., 59 : 176-186 (2011)
 
62) Willett WC, Dietary fats and coronary heart disease. J. Intern. Med., 272 : 13-24 (2012)
PubMed
63) Wu JHY, Lemaitre RN, Imamura F et al., Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease : the Cardiovascular Health Study. Am J. Clin. Nutr., 94 : 431-438 (2011)
 
64) Djousse L, Matthan NR, Lichtenstein AH et al., Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am. J. Cardiol., 110 : 539-544 (2012)
PubMed
65) Kurotani K, Sato M, Ejima Y et al., High levels of stearic acid, palmitoleic acid, and dihomo-γ-linolenic acid and low levels of linoleic acid in serum cholesterol esters are associated with high insulin resistance. Nutr. Res., 32 : 669-675 (2012)
 
66) Bernstein AM, Roizen MF, Martinez L, Purified palmitoleic acid for the reduction of highsensitivity C-reactive protein and serum lipids : a double-blinded, randomized, and placebo controlled study. J. Clin. Lipidol., 8 : 612-617 (2014)
PubMed
67) Schwingshackl L, Hoffmann G, Monounsaturated fatty acids and risk of cardiovascular disease : synopsis of the evidence available from systematic reviews and meta-analysis. Nutrients, 4 : 1989-2007 (2012)
PubMed
68) 農林水産省食品製造卸売課, 我が国の油脂事情 (2012)
 
69) Liu L, Iassonova D, High-oleic canola oils and their food applications. Inform, 23 : 491-495 (2012)
 
70) Slater AM, Dietary fatty acids and cardiovascular disease. Animal, 7 (Suppl. s1) :163-171 (2013)
 
71) Harris WS, Mozaffarian D, Rimm E et al., Omega-6 fatty acids and risk for cardiovascular disease : a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing, and Council on Epidemiology and Prevention. Circulation, 119 : 902-907 (2009)
 
72) Kris-Etherton P, Fleming J, Harris WS et al., The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J. Am. Diet. Assoc., 110 : 201-204 (2010)
 
73) Petrone AB, Weir N, Hanson NQ et al., Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study. Am. J. Clin. Nutr., 97 : 66-71 (2013)
PubMed
74) Ramsden CE, Ringel A, Feldstein AE et al., All PUFAs are not created equal : absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohort. World Rev. Nutr. Diet, 102 : 30-43 (2011)
 
75) Blasbalg TL, Hibbeln JR, Ramsden CE et al., Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr., 93 : 950-962 (2011)
PubMed
76) Ramsden CE, Zamora D, Leelarthaepin B et al., Use of dietary linoleic acid for secondary prevention of coronary heart disease and death : evaluation of recovered data from Sydney Heart Study and updated meta-analysis. BMJ, 346 : e8707 (2013)
PubMed
77) Calder PC, Old study sheds new light on the fatty acids and cardiovascular health debate. BMJ, 346 : f493 (2013)
PubMed
78) Ramsden CE, Ringel A, Feldstein AE et al., Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostagl. Leukot. Essent. Fatty Acids., 87 : 135-141 (2012)
 
79) Gueraud F, Atalay M, Bresgen N et al., Chemistry and biochemistry of lipid peroxydation products. Free Radic. Res., 44 : 1098-1124 (2010)
 
80) Bjermo H, Iggman D, Kullberg J et al., Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inaammation in abdominal obesity : a randomized controlled trial., Am. J. Clin. Nutr., 95 : 1003-1012 (2012)
 
81) Nelson GJ, Schmidt PC, Bartolini G et al., The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids, 32 : 427-433 (1997)
PubMed
82) Kakutani S, Ishikura Y, Tateishi N et al., Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals : a randomized controlled study. Lipids Health Dis., 2011 ; 10 : 241, doi : 10.1186/1476-511X-10-241
PubMed
83) Ooi EMM, Ng TWK, Watts GF et al., Dietary fatty acids and lipoprotein metabolism : new insights and updates. Curr. Opin. Lipidol., 24 : 192-197 (2013)
PubMed
84) Iso H, Kobayashi M, Ishihara J et al., Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese : the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation, 113 : 195-202 (2006)
 
85) Geleijnse JM, de Goede J, Brouwer IA, Alpha-linolenic acid : is it essential to cardiovascular health. Curr. Atheroscler. Rep., 12 : 359-367 (2010)
PubMed
86) Yokoyama M, Origasa H, Matsuzaki M et al., Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS) : a randomised open-label, blinded endpoint analysis. Lancet, 369 : 1090-1098 (2007), Erratum, 370 : 220 (2007)
 
87) Itakura H, Yokoyama M, Matsuzaki M et al., The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid. J. Atheroscler. Thromb., 19 : 673-679 (2012)
PubMed
88) Saito Y. Yokoyama M, Origasa H et al., Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis, 200 : 135-140 (2008).
PubMed
89) Sasaki J, Yokoyama M, Matsuzaki M et al., Relationship between coronary artery disease and non-HDL-C, and effect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins. sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). J. Atheroscl. Thromb., 19 : 194-204 (2011)
 
90) Adkins Y, Kelley DS, Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J. Nutr. Biochem., 21 : 781-792 (2010)
PubMed
91) Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J et al., Long chain omega-3 fatty acids and cardiovascular disease : a systematic review. Brit. J. Nutr., 107 : S201-S213 (2012)
PubMed
92) Kwak SM, Myung SK, Lee YJ et al., Efficacy of omega-3 fatty acid supplements (eicosapetaenoic acid and dososahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch. Intern. Med., 172 : 686-694 (2012)
 
93) Hu FB, Manson JE, Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale? Arch. Intern. Med., 172 : 694-696 ( 2012)
PubMed
94) Rizos EC, Ntzani EE, Bika E et al., Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events : a systematic review and meta-analysis. JAMA, 308 : 1024-1033 (2012)
PubMed
95) The Risk and Prevention Study Collaborative Group, n-3 Fatty acids in patients with multiple cardiovascular risk factors. New Engl. J. Med., 368 : 1800-1808 (2013)
 
96) Simopoulos AP, The omega-6/omega-3 fatty acid ratio, genetic variation and cardiovascular disease. Asia Pacific J. Clin. Nutr., 17 : 131-134 (2008)
 
97) Harris WS, The omega-6/omega-3 ratio and cardiovascular disease risk : uses and abuses. Curr. Atheroscler. Rep., 8 : 456-459 ( 2006)
 
98) Harris WS, Assaad B, Poston WC, Tissue omega-6/omega-3 fatty acid ratio and risk of coronary artery disease. Am. J. Cardiol., 98 : 19i-26i (2006)
PubMed
99) Loef M, Walach H, The omega-6/omega-3 ratio and dementia or cognitive decline : a systematic review on human studies and biological evidence. J. Nutr. Gerontol. Geriatr., 32 : 1-23 (2013)
PubMed
100) Choque B, Cathaline D, Rioux V et al., Linoleic acid : between doubts and certainties. Biochimie, 96 : 14-21 (2014)
 
101) Emken E, Human studies using isotope labeled fatty acids : answered and unanswered questions. J. Oleo Sci., 62 : 245-255 (2013)
PubMed
102) Plourde M, Cannane SC, Extremely limited synthesis of long chain polyunsaturates in adults : implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab., 32 : 619-634 (2007)
 
103) Brenna JT, Salem N Jr., Sinclair AJ et al., α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostagl. Leukot. Essent. Fatty Acids, 80 : 85-91 (2009)
 
104) Koletzko B, Lien E, Agostoni C et al., The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy : review of current knowledge and consensus recommendations. J. Perinat. Med., 36 : 5-14 (2008)
PubMed
105) Koletzko B, Carlson SE, van Goudoever JB, Should infant formula provide both omega-3 DHA and omega-6 arachidonic acid? Ann. Nutr. Metab., 66 : 137-138 (2015)
PubMed
106) 西川正純, 脂肪酸 (α-リノレン酸, EPA・DHA, アラキドン酸). 食品機能性成分の吸収・代謝機構 (宮澤陽夫監修), p.159-166, シーエムシー出版 (2013)
 
107) Serhan CN, Yacoubian S, Yang N, Anti-inaammatory and proresolving lipid mediators. Annu. Rev. Pathol., 3 : 279-312 (2008)
 
108) Adam O, Tesche A, Wolfram G, Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in human. Prostagl. Leukot. Essent. Fatty Acids, 79 : 177-181 (2008)
 
109) Angela Liou Y, Innis SM, Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic acid and eicosapentaenoic acid in plasma of adult men. Prostagl. Leukot. Essent. Fatty Acids, 80 : 201-206 (2009)
 
110) Johnson GH, Fritsche K, Effect of dietary linoleic acid on markers of inflammation in healthy persons : a systematic review of randomized controlled trials. J. Acad. Nutr. Diet., 112 : 1029-1041 (2012)
 
111) Fritsche KL, The science of fatty acids and inaammation. Adv. Nutr., 6 : 293S-301S (2015)
PubMed
112) Nielsen MS, Schmidt EB, Stegger J et al., Adipose tissue arachidonic acid content is associated with the risk of myocardial infarction : a Danish case-cohort study. Atherosclero (2013)
 
113) World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer : a Global Perspective. American Institute for Cancer Research (2007)
 
114) Richman EL, Kenfield SA, Chavarro JE et al., Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern. Med., 173 : 1318-1326 (2013)
PubMed
115) Sakai M, Kakutani S, Horikawa C et al., Arachidonic acid and cancer risk : a systematic review of observational studies. BMC Cancer, 12 : 606 (2012)
 
116) Hibbeln JR, Nieminen LRG, Blasbalg TL et al., Healthy intakes of n-3 and n-6 fatty acids : estimations considering worldwide diversity. Am. J. Clin. Nutr., 83 (6 suppl) : 1483S-1493S (2006)
 
117) Fenton JI, Hord NG, Ghosh S et al., Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostagl. Leukot. Essent. Fatty Acids, 89 : 379-390 (2013)
 
118) Ishikura Y, Ikeda G, Akimoto K et al., Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men. Neuropsychobiology, 60 : 73-79 (2009)
PubMed
119) 榊原学, アラキドン酸を中心とする高度不飽和脂肪酸が加齢脳に及ぼす効果とそのメカニズム. オレオサイエンス, 12 : 273-282 (2012)
 
120) 山口進, アラキドン酸による食品の美味しさ向上効果. オレオサイエンス, 12 : 283-288 (2012)
 
121) Mozaffarian D, Lemaitre RN, King IB et al., Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults : a cohort study. Ann. Intern. Med., 158 : 515-525 (2013)
 
122) 大塚礼, 加藤友紀, 今井具子他, 地域在住中高年男女における性・年齢群別の血清脂肪酸構成比率. 日本栄養・食糧学会誌, 66 : 147-153 (2013)
Medical*Online
123) Otsuka R, Kato Y, Imai T et al., Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79. Lipids, 48 : 719-727 (2013)
PubMed
124) Harris WS, Pottala JV, Varvel SA et al., Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age : observations from 160,000 patients. Prostagl. Leukot. Essent. Fatty Acids, 88 : 257-263 (2013)
 
125) 岡島伸浩, 魚油. 油脂の特性と応用 (戸谷洋一郎監修), p.373-387, 幸書房 (2012)
 
126) Maki KC, Reeves MS, Farmer M et al., Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr. Res., 29 : 609-615 (2009)
PubMed
127) Schuchardt JP, Schneider I, Meyer H et al., Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis., 10 : 145 (2011)
PubMed
128) Ulven SM, Kirkhus B, Lamglait A et al., Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids, 46 : 37-46 (2011)
PubMed
129) Burri L, Hoem N, Banni S et al., Marine omega-3 phospholipids : metabolism and biological activities. Int. J. Mol. Sci., 13 : 15401-15419 (2012)
PubMed
130) Kohler A, Sarkkinen E, Tapola N et al., Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial. Lipids Health Dis., 14 : 19 (2015)
 
131) Yurko-Mauro K, Kralovec J, Bailey-Hall E et al., Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids Health Dis., 14 : 99 (2015)
PubMed
132) Kagan ML, West AL, Zante C et al., Acute appearance of fatty acids in human plasma-a comparative study between polar-lipid rich oil from the microalgae Nannochloropsis oculata and krill oil in healthy young males. Lipids Health Dis., 12 : 102 (2013)
PubMed
133) Nys M, Debruyne I, Global omega-3 summit 2013 highlights. Inform, 24 (9) : S4-S7 (2013)
 
134) Igarashi M, Gao R, Kim HW et al., Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim. Biophys. Acta, 1791 : 132-139 (2009)
 
135) Guesnet P, Lallemand SM, Alessandri JM et al., α-Linolenate reduces the dietary requirement for linoleate in the growing rat. Prostagl. Leukot. Essent. Fatty Acids, 85 : 353-360 (2011)
 
136) Chowdhury R, Wamakula S, Kunutsor S et al., Association of dietary, circulating, and supplement fatty acids with coronary risk : a systematic review and meta-analysis. Ann. Intern. Med., 160 : 398-406, Erratum 658 (2014)
 
137) Farvid MS, Ding M, Pan A et al., Dietary linoleic acid and risk of coronary heart disease : a systematic review and meta-analysis of prospective cohort studies. Circulation, 130 : 1568-1578 (2014)
PubMed
138) EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA), Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal, 8 (3) : 1461 (2010)
 
139) Kromhout D, Geleijnse JM, Menotti A et al., The confusion about dietary fatty acids recommendations for CHD prevention. Brit. J. Nutr., 106 : 627-632 (2011)
PubMed
140) Fairfield K, Review : replacing dietary saturated fatty acids with n-6 polyunsaturated fatty acids does not reduce mortality. Ann. Intern. Med., 158 (10) : JC6 (2013)
 
141) Mozaffarian D, Katan MB, Ascherio A et al., Trans fatty acids and cardiovascular disease. N. Engl. J. Med., 354 : 1601-1633 (2006)
PubMed
142) 食品安全委員会, 新開発食品評価書 食品に含まれるトランス脂肪酸. 2012年3月. http://www.fsc.go.jp/sonota/trans_fat/iinkai422_trans-sibosan_hyoka.pdf
 
143) 菅野道廣監修, 特集 : わが国におけるトランス脂肪酸問題を考える. 明日の食品産業, 通巻425号 : 1-45 (2012)
 
144) Wang Y, Proctor SD, Current issues surrounding the definition of trans-fatty acids : implications for health, industry and food labels. Brit. J. Nutr., 110 : 1369-1383 (2013)
PubMed
145) Yoshinaga K, Kawamura Y, Kitayama T et al., Regiospecific distribution of trans-octadecenoic acid positional isomers in triacylglycerols of partially hydrogenated vegetable oil and ruminant fat. J. Oleo Sci., 64 : 617-624 (2015)
 
146) Tsuzuki W, Inconsistencies in a highly polar capillary gas chromatography column and nescessity of column performance checks for trans fatty acid measurement. J. AOAC Int., 95 : 1740-1743 (2012)
 
147) 渡邉敬浩, 石川智子, 松田りえ子, GC-FIDを用いたトランス脂肪酸分析法の性能評価手法および性能基準値の検討. 食衛誌, 54 : 31-48 (2013)
 
148) 塩田誠, キャピラリーガスクロマトグラフ法によるトランス脂肪酸定量技術. 調理科学会誌, 48 : 229-239 (2015)
 
149) Zook PL, Katan MB, Trans fatty acids, lipoproteins, and coronary risk. Can. J. Physiol. Pharmacol., 75 : 211-216 (1997)
 
150) Ascherio A, Katan MB, Zock PL et al. Trans fatty acids and coronary heart disease. N. Engl. J. Med., 340 : 1994-1998 (1999)
PubMed
151) Hunter JE, Dietary trans fatty acids : review of recent human studies and food industry responses. Lipids, 41 : 967-992 (2006)
PubMed
152) Trumbo PR, Shimakawa T, Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr. Rev., 69 : 270-278 (2011)
PubMed
153) Mozaffarian D, Clarke R, Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr., 63 Suppl 2 : S22-S33 (2009)
 
154) Imamura F, Lemaitre RN, King IB et al., Novel circulating fatty acid patterns and risk of cardiovascular disease : the Cardiovascular Health Study. Am. J. Clin. Nutr., 96 : 1252-1261 (2012)
PubMed
155) Hu FB, Stampfer MJ, Manson JE et al., Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med., 337 : 1491-1499 (1997).
PubMed
156) Kritchevsky D, Trans fatty acids and cardiovascular risk. Prostagl. Leukot. Essent. Fatty Acids, 57 : 399-402 (1997)
 
157) Takeuchi H, Kutsuwada T, Shirokawa Y et al., Supplementation of 1% energy trans fatty acids has little effect on serum cholesterol levels in healthy young Japanese women. Biosci. Biotech. Biochem., 77 : 1219-1222 (2013)
 
158) Mori K, Ishida T, Yasuda T et al., Serum trans-fatty acid concentration is elevated in young patients with coronary artery disease in Japan. Circulation J., 79 : 2017-2025 (2015)
 
159) Thompson AK, Minihane A-M, Williams CM, Trans fatty acids, insulin resistance and diabetes. Eur. J. Clin. Nutr., 65 : 553-564 (2011)
PubMed
160) Tyburczy C, Major C, Lock AL et al., Individual trans octadecenoic acids and partially hydrogenated vegetable oil differently affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. J. Nutr., 139 : 257-263 (2009)
 
161) Meijer GW, von Tol A, van Berkel TJ et al., Effect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster. Atherosclerosis, 157 : 31-40 (2001)
 
162) Lemaitre RN, King IB, Mozaffarian D, Plasma phospholipid trans fatty acids, fetal ischemic heart disease, and sudden cardiac death in older adults : the Cardiovascular Health Study. Circulation, 114 : 209-215 (2006)
 
163) Sun Q, Ma J, Campos H et al., A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation, 115 : 1858-1865 (2007)
 
164) Liu X-R, Deng S-Y, Hu J-N et al., Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability. Brit. J. Nutr., 109 : 1695-1703 (2013)
 
165) Li X-P, Luo T, Li J et al., Linolelaidic acid induces a stronger proliferative effect on human umbilical vein smooth muscle cells compared to elaidic acid. Lipids, 48 : 395-403 (2013)
PubMed
166) Gebauer SK, Chardigny JM, Jakobsen MU et al., Effects of ruminant trans fatty acids on cardiovascular disease and cancer : a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv. Nutr., 2 : 332-354 (2011)
 
167) De Souza RJ, Mente A, Maroleanu A et al., Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes : systematic review and meta-analysis of observational studies. BMJ, 351 : h3978 (2015)
PubMed
168) Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C et al., Is there linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects : results from a systematic review and meta-regression of randomised clinical trials. Brit. J. Nutr. 112 : 1914-1922 (2014)
PubMed
169) Stender S, Astrup A, Dyerberg J, Ruminant and industrially produced trans fatty acids : health aspects. Food Nutr. Res., 2008; 52, doi : 10.3402/fnr.v52i0.1651
 
170) Brouwer IA, Wanders AJ, Katan MB, Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-a quantitative review. PLoS One, 2010 Mar 2; 5 (3) : e9434
 
171) Brouwer IA, Wanders AJ, Katan MB, Trans fatty acids and cardiovascular health : research completed? Eur. J. Clin. Nutr., 67 : 541-547 (2013)
PubMed
172) Laake I, Pedersen JI, Selmer R, A prospective study of intake of trans-fatty acids from ruminant fat, partially hydrogenated vegetable oils, and marine oils and mortality from CVD. Br. J. Nutr., 108 : 743-754 (2012)
PubMed
173) Kuhnt K, Degen C, Jahreis G, Evaluation of the impact of ruminant trans fatty acids on human health : important aspects to consider. Crit. Rev. Food Sci. Nutr., 2015 Mar 6 : 0, [Epub ahead of print]
 
174) Willett WC, Mozaffarian D, Ruminant or industrial sources of trans fatty acids : public health issue or food label skirmish? Am. J. Clin. Nutr., 87 : 515-516 (2008)
 
175) Ganguly R, Pierce GN, The toxicity of dietary trans fats. Food Chem. Toxicol., 76 : 170-176 (2015)
 
176) 食品安全委員会新開発食品専門調査会, 新開発食品評価書 食品に含まれるトランス脂肪酸. 2012年2月. http://www.fsc.go.jp/sonota/trans_fat/iinkai422_trans-sibosan_hyoka.pdf
 
177) Downs SM, Thow AM, Leeder SR, The effectiveness of policies for reducing dietary trans fat : a systematic review of the evidence. Bull. World Health Organ., 91 : 262-269H (2013)
PubMed
178) Rahkovsky I, Martinez S, Kuchler F, New food choices free of trans fats better align U.S. diets with health recommendations. USDA Economic Information Bulletin No. 95, p.1-33 (2012)
 
179) 川端輝江, 兵庫弘夏, 荻原千絵他, 食事の実測による若年女性のトランス脂肪酸摂取量. 日本栄養・食糧学会誌, 61 : 161-168 (2008)
 
180) Angell SY, Cobb LK, Curtis CJ et al., Change in trans fatty acid content of fast-food purchases associated with New York City's restaurant regulation : a pre-post study. Ann. Intern. Med., 157 : 81-86 (2012)
PubMed
181) Watanabe T, Maitani T, Matsuda R, Analysis of trans-fat levels in total diet and one-serving samples using the verified GC-method and estimation of the intake in Japan. Food Hyg. Saf. Sci., 52 : 167-177 (2011)
 
182) Colon-Ramos U, Monge-Rohas R, Campos H, Impact of WHO recommendations to eliminate industrial trans-fatty acids from the food supply in Latin America and Caribbean. Health Policy Plan., 2013 Oct 21, doi : 10.1093/heapol/czt034
 
183) Vannce G, Rasmussen H, Position of the academy of nutrition and dietetics : dietary fatty acids for healthy adults. J. Acad. Nutr. Diet., 114 : 136-153 (2014)
 
184) 白砂尋士, トランス脂肪酸の低減化に向けて. 日本調理科学会誌, 45 : 223-227 (2012)
 
185) Philippaerts A, Jacobs PA, Sels BF, Is there still a future for hydrogenated vegetable oils? Angew. Chem. Int. Ed., 52 : 5220-5226 (2013)
 
186) Pande G, Akoh CC, Enzymatic modification of lipids for trans-free margarine. Lipid Technology, 25 : 31-33 (2013)
 
187) Tyburczy C, Mossoba MM, Rader JI, Determination of trans fat in edible oils : current official methods and overview of recent developments. Anal. Bioanal. Chem., 405 : 5759-5772 (2013)
PubMed
188) Xu L, Zhu X, Chen X et al., Direct FTIR analysis of isolated trans fatty acids in edible oils using disposable polyethylene film. Food Chem., 85 : 503-508 (2015)
 
189) Otite FO, Jacobson MF, Dahmubed A et al., Trends in trans fatty acids reformulations of US supermarket and brand-name foods from 2007 through 2011. Prev. Chronic Dis., 10 : http://dx.doi.org/20.5888/pcd10.120198
 
190) Doell D, Folmer D, Lee H et al., Updated estimate of trans fat intake by the US population. Food Additives Contam., 29 : 861-874 (2012)
 
191) Harris WS, Pottala JV, Vasan RS et al., Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J. Nutr., 142 : 1297-1303 (2012)
PubMed
192) Abraham RA, Bahl VK, Parshad R et al., Content of trans fatty acids in human cheek epithelium : comparison with serum and adipose tissue. BioMed Res. Int., 2013 : Article ID 276174, http://dx.doi.org/10.1155/2013/276174
 
193) 菅野道廣 : トランス脂肪酸の安全性. New Diet Therapy, 28 : 79-82 (2013)
 
194) Federal Register, 64 (No.221) : 64627-62825 (1999) (p.62760参照)
 
195) Allen K, Pearson-Stuttard J, Hooton W et al., Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England : cost effectiveness modeling study. BMJ, 351 : h4583 (2015)
 
196) 丸山武紀, トランス脂肪酸と健康. オレオサイエンス, 13 : 259-266 (2013)
 
197) Ikeda I, Tomari Y, Sugano M et al., Lymphatic absorption of structured glycerolipids containing medium-chain fatty acids and linoleic acid, and their effect on cholesterol absorption in rats. Lipids, 26 : 369-373 (1991)
PubMed
198) Jandacek RJ, Whiteside JA, Holcombe BH et al., The rapid hydrolysis and efficient absorption of triglycerides with ocatanoic acid in the 1 and 3 positions and long-chain fatty acid in the 2 position. Am. J. Clin. Nutr., 45 : 940-945 (1987)
 
199) Mu H, Hoy C-E, Intestinal absorption of specific structured triacylglycerols. J. Lipid Res., 42 : 792-798 (2001)
PubMed
200) Wang J, Yu J-C, Kang W-M et al., Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients : a randomized clinical trial. Nutrition, 28 : 623-629 (2012)
 
201) Cahill GF Jr., Fuel metabolism in starvation. Annu. Rev. Nutr., 26 : 1-22 (2006)
PubMed
202) Wymelbeke VV, Himaya A, Louis-Sylvestre J et al., Influence of medium-chain and long-chain triacylglycerols on control of food intake in men. Am. J. Clin. Nutr., 68 : 226-234 (1998)
 
203) Chiasson J-L, Aris-Jilwan N, Belanger R et al., Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Can. Med. Assoc. J., 168 : 859-866 (2001)
 
204) Metges CC, Wolfram G, Medium- and long-chain triglycerides labeled with 13C : a comparison of oxidation after oral or parenteral administration in humans. J. Nutr., 121 : 31-36 (1991)
PubMed
205) 青山敏明, 中鎖脂肪酸の栄養学的研究-最近の研究を中心に-. オレオサイエンス, 3 : 403-410 (2003)
 
206) Matulka RA, Noguchi O, Nosaka N, Safety evaluation of a medium- and long-chain triacylglycerol oil produced from medium-chain triacylglycerols and edible vegetable oil. Food Chem. Toxicol., 44 : 1530-1538 (2006)
PubMed
207) Timm-Heinrich M, Xu X, Nielsen NS et al., Oxidative stability of structured lipids produced from sunaower oil and caprylic aicd. Eur. J. Lipid Sci. Technol., 105 : 436-448 (2003)
 
208) Nielsen NS, Xu X, Timm-Heinrich M et al., Oxidative stability during storage of structured lipids produced from fish oil and caprylic acid. JAOCS, 81 : 357-384 (2004)
 
209) St-Onge MP, Bosarge A, Weight-loss diet that includes consumption of medium chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am. J. Clin. Nutr., 87 : 621-626 (2008)
PubMed
210) Tsuji H, Kasai M, Takeuchi H et al., Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J. Nutr., 131 : 2853-2859 (2001)
 
211) Kasai M, Nosaka N, Maki H et al., Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pacific J. Clin. Nutr., 12 : 151-160 (2003)
 
212) Ogawa A, Nosaka N, Kasai M et al., Dietary medium- and long-chain triacylglycerols accelerate diet-induced thermogenesis in humans. J. Oleo Sci., 56 : 283-287 (2007)
PubMed
213) Matsuo T, Matsuo M, Kasai M et al., Effect of liquid diet supplement containing structured medium- and long-chain triacylglycerols on body fat accumulation in healthy young subjects. Asia Pacific J. Clin. Nutr., 10 : 46-50 (2001)
 
214) Liu Y, Wan J, Zhang R et al., A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pacific J. Clin. Nutr., 18 : 351-358 (2009)
 
215) Zhang Y, Liu Y, Wang J et al., Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals. Lipids, 45 : 501-510 (2010)
 
216) Mumme K, Stonehouse W, Effects of medium-chain triglycerides on weight loss and body composition : a meta-analysis of randomized controlled trials. J. Acad. Nutr. Diet., 115 : 249-263 (2015)
PubMed
217) Han JR, Deng B, Sun J et al., Effect of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism, 55 : 985-991 (2007)
 
218) Siener R, Ehrhardt C, Bitterlich N et al., Effect of a fat spread enriched with medium-chain triacylglycerols and a special fatty acid-micronutrient combination on cardiometabolic risk factors in overweight patients with diabetes. Nutr. Metab., 8 : 21 (2011)
 
219) Labarthe F, Gelinas R, Des Rosiers C, Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc. Drugs Ther., 22 : 97-106 (2008)
PubMed
220) Pietraszek A, Hermansen K, Pedersen SB et al., Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics. Nutrition, 29 : 1000-1006 (2013)
 
221) 野坂直久, 足立香代子, 川島由紀子他, タンパク・エネルギー低栄養 (PEM) のリスクを保有する高齢者における中鎖脂肪酸摂取が血清アルブミン値に及ぼす影響. 日本臨床栄養学会雑誌, 32 : 52-61 (2010)
 
222) Nosaka N, Suzuki Y, Nagatoishi A et al., Effect of ingestion of medium-chain triaclyglycerols on moderate- and high-intensity exercise in recreational athletes. J. Nutr. Sci. Vitaminol., 55 : 120-125 (2009)
 
223) Costantini LC, Barr LJ, Vogel JL et al., Hypometaboism as a therapeutic target in Alzheimer's disease. BMC Neuroscience, 9 (Suppl 2) : S16 (2008)
 
224) Veech RL, Ketone esters increase brown fat in mice and overcome insulin resistance in other tissues in the rat. Ann. N. Y. Acad. Sci., 1302 : 42-48 (2013)
PubMed
225) Henderson ST, Poirie J, Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease ; a randomized, double-blind, placebo-controlled study. BMC Medical Genetics, 12 : 137 (2011)
 
226) Zhang J, Cao Q, Li S et al., 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism. Biomaterials, 34 : 7552-7562 (2013)
PubMed
227) Gonzalez-Lima F, Barksdale BR, Rohas JC, Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem. Pharamacol., 88 : 584-593 (2014)
 
228) Clarke K, Tchabanenko K, Pawlosky R et al., Kinetics, safety and tolerability of (R) -3-hydroxybutyl (R) -3-hydroxybutyrate in human adult subjects., Regul. Toxicol. Pharmacol., 63 : 401-408 (2012)
PubMed
229) Roberts RO, Roberts LA, Geda YE et al., Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. J. Alzheimer's Dis., 32 : 329-339 (2012)
PubMed
230) Kathleen PA, Williamson A, Yu N et al., Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes, 58 : 1237-1244 (2009)
 
231) Adanyeguh IM, Rinaldi D, Henry PG et al., Triheptanoin imporves brain energy metabolism in patients with Huntington disease. Neurology, 84 : 490-495 (2015)
PubMed
232) 大塚礼, 加藤友紀, 西田裕紀子他, 地域在住高齢者における短鎖および中鎖脂肪酸摂取が8年間の認知機能得点低下に及ぼす影響. 日本栄養・食糧学会誌, 68 : 101-111 (2015)
Medical*Online
233) Wang H, Eckel RH, What are lipoproteins doing in the brain. Trends Endocr. Metab., 25 : 8-14 (2014)
 
234) Rhinn H, Fujita R, Qiang L et al., Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature, 500 (7460) : 45-50 (2013)
 
235) Stukas S, Robert J, Wellington CL, High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease. Cell Metab., 19 : 574-591 (2014)
 
236) Gosselet F, Saint-Pol J, Fenart L, Effects of oxysterols on the blood-brain barrier : implications for Alzheimer's disease. Biochem. Biophys. Res. Commun., 446 : 687-691 (2014)
PubMed
237) Galvin JE, Optimizing diagnosis and management in mild-to-moderate Alzheimer's disease. Neurodegener Dis. Manag., 2 : 291-304 (2012)
 
238) Van Oudenhove L, McKie S, Lassman D et al., Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans. J. Clin. Invest., 121 : 3094-3099 (2011)
PubMed
239) den Besten G, van Eunen K, Groen AK et al., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res., 54 : 2325-2340 (2013)
PubMed
240) Tan J, McKenzie C, Potamitis M et al., The role of short-chain fatty acids in health and disease. Adv. Immunol., 121 : 91-119 (2014)
PubMed
241) Puertollano E, Kolida S, Yaqoob P, Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr. Opin. Clin. Nutr. Metab. Care, 17 : 139-144 (2014)
PubMed

第5章 油脂と肥満

P.185 掲載の参考文献
1) Casazza K, Fontaine KR, Astrup A et al., Myths, presumptions, and facts about obesity. N. Engl. J. Med., 368 : 446-451 (2013)
PubMed
2) Menachemi N, Tajeu G, Sen B et al., Overstatement of results in the nutrition and obesity peerreviewed literature. Am. J. Prev. Med., 45 : 615-621 (2013)
PubMed
3) Waalen J, Avoiding errors in the medical literature. Am. J. Prev. Med., 45 : 672-673 (2013)
PubMed
4) Briggs ADM, Mytton OT, Kehelbacher A et al., Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK : econometric and comparative risk assessment modelling study. BMJ, 347 : f6189 (2013)
PubMed
5) Ogden CL, Carroll MD, Kit BK et al., Prevalence of obesity in the United States, 2011-2012. NCHS Data Brief No.131, January 2013 ; Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA, 311 : 806-814 (2014)
 
6) Tsugane S, Sasaki S, Tsubono Y, Under- and overweight impact on mortality among middle- aged Japanese men and women : a 10-y follow-up of JPHC study cohort I. Int. J. Obesity, 26 : 529-537 (2002)
 
7) Flegal EM, Graubard BI, Williamson DF et al., Excess deaths associated with underweight, overweight, and obesity. JAMA, 293 : 1861-1867 (2005)
 
8) Katzmarzyk P, Mire E, Bray GA et al., Anthropometric markers of obesity and mortality in white and African American adults : The Pennington Center Longtitudinal Study. Obesity (Silver Spring), 21 : 1070-1075 (2013)
 
9) Sadler MH, McNulty H, Gibson S, Sugar-fat seesaw : a systematic review of the evidence. Crit. Rev. Food Sci. Nutr., 55 : 338-356 (2015)
 
10) Dietary Fat Consensus Statements. Am. J. Med., 113 (Suppl. 9B) : 5-8 (2002)
 
11) Hooper L, Abdelhamid A, Moore HJ et al., Effect of reducing total fat intake on body weight : systematic review and meta-analysis of randomized controlled trials and cohort studies. BMJ, 345 : e7666 (2012)
PubMed
12) Gardner CD, Kiazand A, Alhassan S et al., Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. The A to Z Weight Loss Study : a randomized trial. JAMA, 297 : 969-977 (2007)
 
13) Shai I, Schwarzfuchs D, Henkin Y et al., Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med., 359 : 229-241 (2008)
 
14) Schwarzfuchs D, Golan R, Shai I, Four-year follow-up after two-year dietary interventions. N. Engl. J. Med., 367 : 1373-1374 (2012)
PubMed
15) Forouchi NG, Sharp SJ, Du H et al., Dietary fat intake and subsequent weight change in adults : results from the European Prospective Investigation into Cancer and Nutrition cohorts. Am J. Clin. Nutr., 90 : 1632-1641 (2009)
 
16) Bueno NB, de Melo IS, de Oliveira SL et al., Very-low-carbohydrate ketogenic diet v. low- fat diet for long-term weight loss : a meta-analysis of randomized controlled trials. Br. J. Nutr., 110 : 1178-1187 (2013)
 
17) Gross LS, Li L, Ford ES et al., Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States : an ecologic assessment. Am. J.Cin. Nutr., 79 : 774-779 (2004)
 
18) Sacks FM, Bray GA, Carey VJ et al., Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med., 360 : 859-873 (2009)
PubMed
19) Hansen A, Swedish health advisory body says too much carbohydrate, not fat, leads to obesity. BMJ, 347 : f6873 (2013) (Swedish Council on Health Technology Assessment. Diet and obesity : a systematic review of the literature. Sep 2013)
PubMed
20) Santos FL, Esteves SS, da Costa Pereira A et al., Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obesity Rev., 13 : 1048-1066 (2012)
PubMed
21) Shikany JM, Vaughan LK, Baskin ML et al., Is dietary fat "fattening"? A comprehensive research synthesis. Crit. Rev. Food Sci. Nutr., 50 : 699-715 (2010)
PubMed
22) Field AE, Willett WC, Lissner L et al., Dietary fat and weight gain among women in the Nurses' Health Study. Obesity, 15 : 967-976 (2007)
PubMed
23) Corella D, Arnett DK, Tucker KL et al., A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J. Nutr., 141 : 2219-2225 (2011)
PubMed
24) Krishnan S, Cooper JA, Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in human. Eur. J. Nutr., 53 : 691-710 (2014)
PubMed
25) Position of the Academy of Nutrition and Dietetics : Dietary fatty acids for healthy adults. J. Acad. Nutr. Diet., 114 : 136-153 (2014)
 
26) Buckley JD, How PRC, Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obesity Rev., 10 : 648-659 (2009)
 
27) Hill AM, Buckley JD, Murphy KJ et al., Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular risk factors. Am. J. Clin. Nutr., 85 : 1267-1274 (2007)
PubMed
28) Harden CJ, Dible VA, Russell JM et al., Long-chain polyunsaturated fatty acid supplementation had no effect on body weight but reduced energy intake in overweight and obese women. Nutr. Res., 34 : 17-24 (2014)
PubMed
29) Martinez-Victoria E, Yago MD, Omega 3 polyunsaturated fatty acids and body weight. Br. J. Nutr., 107 (Suppl.2) : S107-S116 (2012)
 
30) Donahue SM, Rofas-Shiman SL, Gold DR et al., Prenatal fatty acid status and child adiposity at age 3 y : results from a US pregnancy cohort. Am. J. Clin. Nutr., 93 : 780-788 (2011)
 
31) Rosqvist F, Iggman D, Kullberg J et al., Overfeeding polyunsaturated and satutated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes, 63 : 2356-2368 (2014)
PubMed
32) Kratz M, Baars T, Guyenet S, The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur. J. Nutr., 52 : 1-24 (2012)
PubMed
33) Holmberg S, Thelin S, High dairy fat intake related to less central obesity : a male cohort study with 12 years' follow up. Scand. J. Prim. Health Care, 31 : 89-94 (2013)
 
34) Fekete K, Gyorei E, Lohner S et al., Long-chain polyunsaturated fatty acid status in obesity : a systematic review and meta-analysis. Obesity Rev., 16 : 488-497 (2015)
PubMed
35) Ezaki O, The optimal dietary fat to carbohydrate ratio to prevent obesity in the Japanese population : a review of the epidemiological, physiological and molecular evidence. J. Nutr. Sci. Vitaminol., 57 : 383-393 (2011)
PubMed
36) Nagata C, Nakamura K, Wada K et al., Total fat intake is associated with decreased mortality in Japanese men but not in women. J. Nutr., 142 : 1713-1719 (2012)
 
37) Ichimura A, Hirasawa A, Poulain-Godefroy O et al., Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature, 483 (7389) : 350-354 (2012)
PubMed
38) Tsukita S, Yamada T, Uno K et al., Hepatic glucokinase modulates obesity predisposition by regulating BAT thermogenesis via neural signals. Cell Metab., 16 : 825-832 (2012)
PubMed
39) Yoneyama S, Guo Y, Lanktree MB et al., Gene-centric meta-analysis of central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations. Hum. Mol. Genet., 23 : 2498-2510 (2014)
PubMed
40) Qi Q, Chu GC, Kang JH et al., Fried food consumption, genetic risk, and body mass index : genediet interaction analysis in three US cohort studies. BMJ, 348 : g1610 (2014)
 
41) Kajimura S, Saito M, A new era in brown adipose tissue biology : molecular control of brown fat development and energy homeostasis. Annu. Rev. Physiol., 76 : 225-249 (2014)
 
42) Reddy NL, Jones TA, Wayte SC et al., Identification of brown adipose tissue using MR imaging in a human adult with histological and immunohistrochemical confirmation. J. Clin. Endocrinol. Metab., 99 : E117-E121 (2014)
 
43) Villarroya J, Cereijo R, Villarroya F, An endocrine role for brown adipose tissue? Am. J. Physiol. Endocrinol. Metab., 305 : E567-E572 (2013)
PubMed
44) Harms M, Seale P, Brown and beige fat : development, function and therapeutic potential., Nature Med., 19 : 1252-1263 (2013)
 
45) Dulloo AG, Translational issues in targeting brown adipose tissue thermogenesis for human obesity management. Ann. N. Y. Acad. Sci., 1302 : 1-10 (2013)
PubMed
46) Heeren J, Munzberg H, Novel aspects of brown adipose tissue biology. Endocrinol. Metab. Clin. North Am., 42 : 89-107 (2013)
PubMed
47) Townsend KL, Tseng Y-H, Brown fat fuel utilization and thermogenesis. Trends Endocrinol. Metab., 25 : 168-177 (2014)
PubMed
48) Saito M, Human brown adipose tissue : regulation and anti-obesity potential. Endocr. J., 61 : 409-416 (2014)
PubMed
49) Tupone D, Madden CJ, Morrison SF, Automic regulation of brown adipose tissue thermogenesis in health and disease : potential clinical applications for altering BAT thermogenesis. Frontiers Nurosci., 8 (Article 14) : 1-14 (2014)
 
50) Veech RL, Ketone esters increase brown fat in mice and overcome insulin resistance in other tissues in the rat. Ann. N.Y. Acad. Sci., 1302 : 42-48 (2013)
PubMed
51) Dulloo AG, The search for compounds that stimulate thermogenesis in obesity management : from pharmaceuticals to functional food ingredients. Obes. Res., 12 : 866-883 (2011)
 
52) Schwingshackl L, Hoffmann G, Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients : a systematic review and meta-analysis. J. Acad. Nutr. Diet., 113 : 1640-1661 (2013)
PubMed
53) 日本油化学会編, 油脂の栄養価. 油脂・脂質・界面活性剤データブック, 丸善, p.77-80 (2012) および佐藤匡央, 城内文吾私信
 
54) Iwasaki M, Yamamoto S, Otani T et al., Generalizability of relative risk estimates from a well-defined population to a general population. Eur. J. Epidemiol., 21 : 253-262 (2006)
PubMed
55) Despres JP, Body fat distribution and risk of cardiovascular disease : an update. Circulation, 126 : 1301-1303 (2012)
PubMed
56) Casas-Agustench P, Arnett DK, Smith CE et al., Saturated fat intake modulates the association between an obesity genetic risk score and body mass index in two US populations. J. Acad. Nutr. Diet., 114 : 1954-1966 (2014)
PubMed
57) Nicklas TA, O'Neil CE, Fulgoni VL, Rice consumption is associated with better nutrient intake and diet quality in adults : National Health and Nutrition Examination Survey (NHANES) 2005-2010. Food Nutr. Sci., 5 : 525-532 (2014)
 
58) Muraki I, Wu H, Imamura F et al., Rice consumption and risk of cardiovascular disease : results from a pooled analysis of 3 U.S. cohorts. Am J. Clin. Nutr., 101 : 164-172 (2015)
PubMed
59) WHO, Guideline : Sugar Intake for Adults and Children, Geneva : World Health Organization ; 2015
 
60) Garaulet M, Gomez-Abellan P, Timing of food intake and obesity : a novel association. Physiol. Behav., 134 : 44-50 (2014)
PubMed
61) Bays HE, Toth PP, Kris-Etherton PM et al., Obesity, adiposity, and dyslipidemia : a consensus statement from the National Lipid Association. J. Clin. Lipidol., 7 : 304-383 (2013)
PubMed
62) Jensen MD, Ryan DH, Apovian CM et al., 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults : a report for the American College of Cardiology/American Heart Association task force on Practice Guidelines and The Obesity Society. Circulation, 129 (Suppl.2) : S139-S140 (2014)
 
63) Kiszko KM, Martinez OD, Abrams C et al., The inauence of calorie labeling on food orders and consumption : a review of the literature. J. Community Health, 39 : 1248-1269 (2014)
PubMed
64) Kitahara CM, Flint AJ, de Gonzalez AB et al., Association between class III obesity (BMI of 40-59 kg/m2) and mortality : a pooled analysis of 20 prospective studies. PLoS Med., 11 (7) : e1001673 (2014)
 
65) Biguzzi C, Schlich P, Lange C, The impact of sugar and fat reduction on perception and liking of biscuits. Food Quality Pref., 35 : 41-47 (2014)
 

第6章 コレステロールの栄養学

P.214 掲載の参考文献
1) 村松芳多子, 土橋昇, 田中恵美子他, 日本人のコレステロールおよび脂肪酸推定摂取量. 千葉県立衛生短大紀要, 23 : 1-25 (2005)
 
2) Lecerf J-M, de Lorgeril M, Dietary cholesterol : from physiology to cardiovascular risk. Br. J. Nutr., 106 : 6-14 (2011)
PubMed
3) Hui DY, Howles PN, Molecular mechanisms of cholesterol absorption and transport in the intestine. Seminars Cell Develop. Biol., 16 : 183-192 (2005)
 
4) Turley SD, Role of Niemann-Pick C1-Like 1 (NPC1L1) in intestinal sterol absorption. J. Clin. Lipidol., 2 : 520-528 (2008)
 
5) Betters JL, Yu L, NPC1L1 and cholesterol transport. FEBS Lett., 584 : 2740-2747 (2010)
PubMed
6) von Bergmann K, Sudhop T, Lutjohann D, Cholesterol and plant sterol absorption : recent insights. Am. J. Cardiol., 96 (1A) : 10D-14D (2005)
PubMed
7) Anderson RGW, Joe Goldstein and Mike Brown : from cholesterol homeostasis to new paradigms in membrane biology. Trend Cell Biol., 13 : 534-539 (2003)
 
8) Fernandez ML, West KL, Mechanism by which dietary fatty acid modulate plasma lipids. J. Nutr., 135 : 2075-2078 (2005)
PubMed
9) Iso H, Jacobs DR, Wentworth D et al., Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med., 320 : 904-910 (1989)
 
10) Okamura T, Tanaka H, Miyamatsu N et al., The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japaneses cohort. Atherosclerosis, 190 : 216-223 (2007)
PubMed
11) Hegsted DM, Serum-cholesterol response to dietary cholesterol : a re-evaluation. Am. J. Clin. Nutr., 44 : 299-305 (1986)
PubMed
12) Weggemans RM, Zock PL, Katan MB, Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans : a meta-analysis. Am. J. Clin. Nutr., 73 : 885-891 (2001)
PubMed
13) Huth PJ, Park KM, Inauence of dairy product and milk fat consumption on cardiovascular disease risk : a review of the evidence. Adv. Nutr., 3 : 266-285 (2012)
 
14) Laurence GD, Dietary fats and health : dietary recommendations in the context of scientific evidence. Adv. Nutr., 4 : 294-302 (2013)
 
15) Kanter MM, Kris-Etherton PM, Fernandez ML et al., Exploring the factors that affect blood cholesterol and heart disease risk : is dietary cholesterol as bad for you as history leads us to believe? Adv. Nutr., 3 : 711-717 (2012)
 
16) Li Y, Zhou C, Zhou X et al., Egg consumption and risk of cardiovascular diseases and diabetes : a meta-analysis. Atherosclerosis, 229 : 524-530 (2013)
 
17) Lee CT, Liese AD, Lorenzo C et al., Egg consumption and insulin metabolism in the Insulin Resistance Atherosclerosis Study (IRAS). Public Health Nutr., 17 : 1596-1602 (2014)
 
18) Kurotani K, Nanri A, Goto A et al., Cholesterol and egg intakes and the risk of type 2 diabetes : the Japan Public Health Center-based Prospective Study. Br. J. Nutr., 112 : 1636-1643 (2014)
PubMed
19) Fuller NR, Caterson ID, Sainsbury A et al., The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes : the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. Am. J. Clin. Nutr., 101 : 705-713 (2015)
PubMed
20) Virtanen JK, Mursu J, Tuomainen T-P et al., Egg consumption and risk of incident type 2 diabetes in men : the Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Clin. Nutr., 101 : 1088-1096 (2015)
PubMed
21) Blesso CN, Andersen CJ, Barona J et al., Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome. Metabolism, 62 : 400-410 (2013)
PubMed
22) 中村保幸, JPHC-動脈硬化と生活習慣-. The Lipid, 22 : 20-25 (2011)
 
23) Homma Y, Kobayashi T, Yamaguchi H et al., Apolipoprotein-E phenotype and basal activity of lowdensity lipoprotein receptor are independent of changes in plasma lipoprotein subfractions after cholesterol ingestion in Japanese subjects. Nutrition, 17 : 310-314 (2001)
PubMed
24) Asato L, Wang M-F, Chan Y-C et al., Effect of egg white on serum cholesterol concentration in young women. J. Nutr. Sci. Vitaminol., 42 : 87-96 (1996)
PubMed
25) Spence JD, Jenkins DJ, Davignon J, Dietary cholesterol and egg yolks : not for patients at risk of vascular disease. Can J Cardiol., 226 : e336-e339 (2010)
 
26) Spence JD, Jenkins DJ, Davignon J, Egg yolk consumption and carotid plaque. Atherosclerosis, 224 : 469-473 (2012)
PubMed
27) Voutilainen S, Nurmi A, Mursu J et al., Regular consumption of eggs does not affect carotid plaque area or risk of acute myocardial infarction in Finnish men. Atherosclerosis, 227 : 186-188 (2013)
PubMed
28) Ruxton C, Recommendations for the use of eggs in the diet. Nurs. Stand., 24 (37) : 47-55 (2010)
PubMed
29) Ruxton C, Derbyshire E, Gibson S, The nutritional properties and health benefits of eggs, Nutr. Food Sci., 40 : 263-279 (2010)
 
30) Silbernagel C, Chapman MJ, Genser B et al., High intestinal cholesterol absorption is associated with cardiovasculr disease and risk alleles in ABCG8 and ABO : evidence from the LURIC and YFS cohorts and from meta-analysis. J. Am. Coll. Cardiol., 62 : 291-299 (2013)
 
31) Chowdhury R, Wamakula S, Kunutsor S et al., Association of dietary, circulating, and supplement fatty acids with coronary risk : a systematic review and meta-analysis. Ann. Intern. Med., 160 : 398-406, Erratum 658 (2014)
 
32) Diffenderfer MR, Schaefer EJ, The composition and metabolism of large and small LDL. Curr. Opin. Lipidol., 25 : 221-226 (2014)
PubMed
33) Ramsden CE, Hibbeln JR, Majchrzak-Hong SF, All PUFAs are not created equal : absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. World Rev. Nutr. Diet., 102 : 30-43 (2011)
 
34) Bazinet RP, Chu MWA, Omega-6 polyunsaturated fatty acids : is a broad cholesterol-lowering health claim appropriate? CMAJ, 186 : 434-439 (2014)
PubMed
35) Dias CB, Garg R, Wood LG et al., Saturated fat consumption may not be the main cause of increased blood lipid levels. Med. Hypothesis, 82 : 187-195 (2014)
 
36) von Schacky C, Omega-3 fatty acids in cardiovascular disease-an uphill battle. Prostagl. Leukot. Essent. Fatty Acids, 92 : 41-47 (2015)
 
37) Laidlaw M, Cockerline CA, Row WJ, A randomized clinical trial to determine the efficacy of manufacturer's recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction. Lipids Health Dis., 13 : 99 (2014)
 
38) Srigley CT, Rader JI, Content and composition of fatty acids in marine oil omega-3 supplements. J. Agr. Food Chem., 62 : 7268-7278 (2014)
 
39) Stone NJ, Robinson JG, Lichtenstein AH et al., 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol, 63 (25 PtB) : 2889-2934 (2014)
 
40) Sinatra ST, Teter BB, Bowden J et al., The saturated fat, cholesterol, and statin controversy a commentary. J. Am. Coll. Nutr., 33 : 79-88 (2014)
PubMed
41) Desai CS, Martin SS, Blumenthal RS, Non-cardiovascular effects associated with statins. BMJ, 349 : g3743 (2014)
PubMed
42) 日本動脈硬化学会, ACC/AHA ガイドラインに対する日本動脈硬化学会の見解. http://www.j-athero.org/outline/gudeline_comment.html, Koba S, Maruyama C, Sasaki J, Comment on the 2013 ACC/AHA guidelines on lifestyle management to reduce cardiovascular risk by the JAS guidelines committee. J. Atheroscler. Thromb., 21 : 375-377 (2014)
 
43) Jacobs RJ, Voorneveld PW, Kodach LL et al., Cholesterol metabolism and colorectal cancers. Curr. Opin. Pharmacol., 12 : 690-695 (2012)
PubMed
44) Krycer JR, Brown AJ, Cholesterol accumulation in prostate cancer : a classic observation from a modern perspective. Biochim. Biophys. Acta, 1835 : 219-229 (2013)
PubMed
45) Kotani K, Sekine Y, Ishikawa S et al., High-density lipoprotein and prostate cancer : an overview. J. Epidemiol., 23 : 313-319 (2013)
PubMed
46) Danilo C, Frank PG, Cholesterol and breast cancer development. Curr. Opin. Pharamacol., 12 : 677-682 (2012)
PubMed
47) Poirot M, Silvente-Poirot S, Cholesterol-5,6-epoxides : chemistry, biochemistry, metabolic fate and cancer. Biochime, 95 : 622-631 (2013)
 
48) Drabkin HA, Gemmill RM, Cholesterol and the development of clear-cell renal carcinoma. Curr. Opin. Pharmacol., 12 : 742-750 (2012)
PubMed
49) 長田恭一, 照沼彰一郎, 食事中の酸化コレステロールをめぐる諸問題. 日本臨床栄養学会雑誌, 34 : 146-150 (2012)
Medical*Online
50) Paniangvait P, King AJ, Jones AP et al., Cholesterol oxides in foods of animal origin. J. Food Sci., 60 : 1159-1174 (1995)
 
51) 市育代, 岩本昌子, 友寄博子他, 日本人におけるコレステロール酸化物と植物ステロール酸化物の摂取量. 日本栄養・食糧学会誌, 58 : 145-149 (2005)
Medical*Online
52) 佐藤匡央, 城内文吾, 酸化コレステロールの生理的意義. オレオサイエンス, 12 : 115-123 (2012)
 
53) Poli G, Biasi F, Leonarduzzi G, Oxysterol in the pathogenesis of major chronic diseases. Redox Biol., 1 : 125-130 (2013)
PubMed
54) Brown AJ, Jessup W, Oxysterols and atherosclerosis. Atherosclerosis, 142 : 1-28 (1999)
PubMed
55) Bjorkhem I, Five decades with oxysterols. Biochime, 95 : 448-454 (2013)
 
56) Nunes VS, Panzoldo NB, Leanca CC et al., Increased 27-hydroxycholesterol plasma level in men with low high density lipoprotein-cholesterol may circumvent their reduced cell cholesterol efflux rate. Clin. Chim. Acta, 433 : 169-173 (2014)
PubMed
57) Saeed AA, Genove G, Li T et al., Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain., J. Biol. Chem., 289 : 23712-23722 (2014)
 
58) Iuliano L, Crick PJ, Zerbinati C et al., Cholesterol metabolites exported from human brain. Steroids, 99 (PtB) : 189-193 (2015)
 
59) Nelson ER, Wardell SE, Jasper JS et al., 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science, 342 : 1094-1098 (2013)
PubMed
60) Yoshida Y, Saito Y, Hayakawa M et al., Levels of lipid peroxidation in human plasma and erythrocytes : comparison between fatty acids and cholesterol. Lipids, 42 : 439-449 (2007)
PubMed
61) Terao J, Cholesterol hydroperoxides and their degradation mechanism. Subcell. Biochem., 77 : 83-91 (2014)
PubMed
62) Tremblay-Franco M, Zerbinati C, Pacelli A et al., Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human. Steroids, 99 (PtB) : 287-292 (2015)
 
63) McNamara DJ, Dietary cholesterol, heart disease risk and cognitive dissonance. Proc. Nutr. Soc., 73 : 161-166 (2014)
PubMed
64) 日本脂質栄養学会監修, 作用メカニズムから見たコレステロール低下医療の危険性. 西海出版 (2014)
 
65) Khan NA, Raine LB, Drollette ES et al., The relation of saturated fats and dietary cholesterol to childhood cognitive aexibility. Appetite, 93 : 51-56 (2015)
PubMed
66) McNamara DJ, The fifty year rehabilitation of the egg. Nutrients, 7 : 8716-8722 (2015)
PubMed

第7章 植物ステロールの栄養学

P.235 掲載の参考文献
1) Pollak OJ, Kritchevsky D, Sitosterol. Monographs on Atherosclerosis 10, Karger (1981)
 
2) 原健次, 植物ステロールの生化学と応用, 幸書房 (2011)
 
3) 戸谷洋一郎監修, 油脂の特性と応用, p.83, 幸書房 (2012)
 
4) 日本栄養・食糧学会編, 栄養・食糧学データハンドブック, p.155-158, 同文書院 (2006)
 
5) 日本油化学会編, 油脂・脂質・界面活性剤データブック, p.69-74, 丸善出版 (2012)
 
6) Cusack LK, Fernandez ML, Volek JS, The food matrix and sterol characteristics affect the plasma cholesterol lowering of phytosterol/phytostanol. Adv. Nutr., 4 : 633-643 (2013)
PubMed
7) Ozawa Y, Sato H, Nakatani A et al., Chemical composition of soybean oil extracted from hypocotyle-enriched soybean raw material and its cholesterol lowering in rats. J. Oleo Sci., 50 : 217-223 (2001)
 
8) Katan MB, Grundy SM, Jones P et al., Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc., 78 : 965-978 (2003)
PubMed
9) Gylling H, Plat J, Turley S et al., Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis, 232 : 346-360 (2014)
PubMed
10) 斎藤信一郎, 池田郁男, 菅野道廣, 植物ステロール/スタノールの血中コレステロール低下効果-最少有効摂取量について-. 日本栄養・食糧学会誌, 55 : 177-189 (2002)
 
11) Kurokawa M, Masuda Y, Noda M et al., Minimal effective dose on serum cholesterol concentration and safety evaluation of dressing containing plant sterol in Japanese subjects. J. Oleo Sci., 57 : 23-33 (2008)
PubMed
12) Clifton P, Inauence of food matrix on sterol and stanol activity. J. AOAC Int., 98 : 677-678 (2015)
PubMed
13) Sato H, Ito K, Morinaga Y et al., Effects of soybean-germ oil on reducing serum cholesterol level. J. Oleo Sci., 50 : 649-655 (2001)
 
14) H. Sato, Ito K, Sakai K et al., Effects of soybean-germ oil on reducing serum cholesterol leves in a double-blind controlled trial in healthy humans. J. Oleo Sci., 53 : 9-16 (2004)
 
15) Ikeda I, Sugano M, Comparison of absorption and metabolism of β-sitosterol and β-sitostanol in rats. Atherosclerosis, 30 : 227-237 (1978)
 
16) Ikeda I, Kawasaki A, Samezima K et al., Antihypercholesterolemic activity of β-sitostanol in rabbits. J. Nutr. Sci. Vitaminol., 27 : 243-251 (1981)
 
17) O'Neill FH, Brynes A, Mandeno R et al., Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr. Metab. Cardiovasc. Dis., 14 : 133-142 (2004)
 
18) Miettinen TA, Gylling H, Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann. Med., 36 : 126-134 (2004)
PubMed
19) Talati R, Sobieraj DM, Makanni SS et al., The comparative efficacy of plant sterols and stanols on serum lipids : a systematic review and meta-analysis. J. Am. Diet. Assoc., 110 : 719-726 (2010)
 
20) Musa-Veloso K, Poon TH, Elliot JA et al., A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range : results of a meta-analysis of randomized, placebo-controlled trials. Prostagl. Leukot. Essent. Fatty Acids, 85 : 9-28 (2011)
 
21) Plat J, Baumgartner S, Mensink RP, Mechanisms underlying the health benefits of plant sterol and stanol ester consumption. J. AOAC Int., 98 : 697-700 (2015)
PubMed
22) Laitinen K, Gylling H, Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption : clinical evidence. Lipids Health Dis., 11 : 140 (2012)
PubMed
23) Smet ED, Mensink RP, Plat J, Effects of plant sterols and stanols on intestinal cholesterol metabolism : suggested mechanisms from past to present. Mol. Nutr. Food Res., 56 : 1058-1072 (2012)
 
24) Carden TJ, Hang J, Dussault PH et al., Dietary plant sterol esters must be hydrolyzed to reduce intestinal cholesterol absorption in hamsters. J. Nutr., 145 : 1402-1407 (2015)
PubMed
25) Plat J, Mensink RP, Plant stanol and sterol esters in the control of blood cholesterol levels : mechanism and safety aspects. Am. J. Cardiol., 96 (1A) : 15D-22D (2005)
PubMed
26) Homma Y, Ikeda I, Ishikawa T et al., Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesterol ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread : a randomized, placebo-controlled trial. Nutrition, 19 : 369-374 (2003)
 
27) Fardet A, Morise A, Kalonji E et al., Inauence of phytosterol and phytostanol food supplementation on plasma liposoluble vitamins and provitamin A carotenoid levels in humans : an updated review of the evidence. Crit. Rev. Food Sci. Nutr., 20 Jul 2015, doi : 10.1080/10408398.2015.1033611
 
28) Patel SB, Plant sterols and stanols : their role in health and disease. J. Clin. Lipidol., 2 : 511-519 (2008)
 
29) Kato M, Ito Y, Tanaka Y et al., SHRSP/Izm and WKY/NCrlCrlj rats having a missense mutation in Abcg5 deposited plant sterols in the body, but did not change their biliary secretion and lymphatic absorption-comparison with Jcl : Wistar and WKY/Izm rats. Biosci. Biotechnol. Biochem., 76 : 660-664 (2012)
 
30) Hamada T, Goto H, Yamahira T et al., Solubility in and affinity for the bile salt micelle of plant sterols are important determinants for their intestinal absorption in rats. Lipids, 41 : 551-556 (2006)
PubMed
31) Grattan BJ Jr, Plant sterols as anticancer nutrients : evidence for their role in breast cancer. Nutrients, 5 : 359-387 (2013)
PubMed
32) Ramprasath VR, Awad AB, Role of phytosterols in cancer prevention and treatment. J. AOAC Int., 98 : 735-738 (2015)
PubMed
33) Kelly ER, Plat J, Mensink RP et al., Effects of long term plant sterol and -stanol consumption on the retinal vasculature : a randomized controlled trial in statin users. Atherosclerosis, 214 : 225-230 (2011)
PubMed
34) Demonty I, Ras RT, van der Knaap HCM et al., The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations : a pooled analysis of 12 randomised controlled trials. Eur. J. Nutr., 52 : 153-160 (2012)
PubMed
35) Rideout TC, Marinangeli CP, Harding SV, Triglyceride-lowering response to plant sterol and stanol consumption. J. AOAC Int., 98 : 707-715 (2015)
PubMed
36) Ryan E, McCarthy FO, Maguire AR et al., Phytosterol oxidation products : their formation, occurrence, and biological effects. Food Rev. Int., 25 : 157-174 (2009)
 
37) Dutta P, Phytosterol oxidation in foods and food products. Inform, 23 : 265-267 (2012)
 
38) Alemany L, Barbera R, Alegria A et al., Plant sterols from foods in inflammation and risk of cardiovascular disease : a real threat? Food Chem. Toxicol., 69 : 140-149 (2014)
PubMed
39) Rudzinska M, Przybylski MR, Wasowicz E et al., Degradation of phytosterols during storage of enriched margarine. Food Chem., 142 : 294-298 (2014)
 
40) Gawrysiak-Witulska M, Rudzinska M, Wawrzyniak J et al., The effect of temperature and moisture content of stored rapeseed on the phytosterol degradation rate. J. Am. Oil. Chem. Soc., 89 : 1673-1679 (2012)
 
41) Baumgartner S, Mensink RP, den Hartog G et al., Oxyphytosterol formation in humans : identification of high vs. low oxidizers. Biochem. Pharmacol., 86 : 19-25 (2013)
 
42) Ikeda I, Konno R, Shimizu T et al., Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. Biochim. Biophys. Acta, 1760 : 800-807 (2006)
PubMed
43) O'Callaghan Y, McCarthy FO, O'Brien NM, Recent advances in phytosterol oxidation products. Biochem. Biophys. Res. Commun., 446 : 786-791 (2014)
PubMed
44) Weingartner O, Teupser D, Patel SB, The atherogenicity of plant sterols : the evidence from genetics to clinical trials. J. AOAC Int., 98 : 742-749 (2015)
PubMed
45) Ras RT, Demonty I, Zebregs YEMP et al., Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women. J. Nutr., 144 : 1564-1570 (2014)
 
46) Shaghaghi MA, Abumweis SS, Jones PJH, Cholesterol-lowering efficacy of plant sterols/stanols provided in capsule and tablet formats : results of a systematic review and meta-analysis. J. Acad. Nutr. Diet., 113 : 1494-1503 (2013)
 
47) Weingartner O, Baber R, Teupser D, Plant sterols in food : no consensus in guidelines. Biochem. Biophys. Res. Commun., 446 : 811-813 (2014)
PubMed
48) Silbernagel G, Baumgartner I, Marz W, Cardiovascular safety of plant sterol and stanol consumption. J. AOAC Int., 98 : 739-741 (2015)
PubMed
49) Windler E, Zyriax B-C, Kuipers F et al., Association of plasma phytosterol concentration with incident coronary heart disease. Data from the CORA study, a case-control study of coronary artery disease in women., Atherosclerosis, 203 : 284-290 (2009)
PubMed
50) Ras RT, van der Schouw YT, Trautwein EA et al., Intake of phytosterols from natural sources and risk of cardiovascular disease in the European Prospective Investigation into Cancer and Nutrition-the Netherlands (EPIC-NL) population. Eur. J. Prev. Med., 22 : 1067-1075 (2015)
 
51) Stock J, Focus on lifestyle : EAS consensus panel position statement on phytosterol-added foods. Atherosclerosis, 214 : 142-145 (2014)
 
52) AbuMweis SS, Marinangeli CP, Frohilich J et al., Implementing phytosterols into medical practice as a cholesterol-lowering strategy : overview of efficacy, effectiveness, and safety. Can. J. Cardiol., 30 : 1225-1232 (2014)
PubMed
53) Ras RT, Geleijnse JM, Trautwein EA, LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges : a meta-analysis of randomized controlled studies. Br. J. Nutr., 112 : 214-219 (2014)
PubMed
54) Uddin S, Sarker ZI, Ferdosh S et al., Phytosterols and their extraction from various plant matrices using supercritical carbon dioxide : a review. J. Sci. Food Agric., 95 : 1385-1394 (2015)
 

第8章 脂質の食事摂取基準

P.249 掲載の参考文献
1) 菱田明, 佐々木敏監修, 日本人の食事摂取基準, 厚生労働省「日本人の食事摂取基準 (2015年版)」策定検討会報告書. 第一出版 (2014)
 
2) Yamagishi K, Iso H, Kokubo Y et al., Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities : the JPHC Study. Eur. Heart J., 34 : 1225-1232 (2013)
PubMed
3) Farvid MS, Ding M, Pan A et al., Dietary linoleic acid and risk of coronary heart disease : a systematic review and meta-analysis of the prospective cohort studies. Circulation, 130 : 1568-1578 (2014)
PubMed
4) Hooper L, Summerbell CD, Thompson R et al., Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev., 2011; (7) : CD002137
 
5) Hawkes N, Too soon to discard advice against saturated fats, professors say. BMJ, 349 : g6114 (2014)
 
6) Li Y, Hruby A, Bernstein AM et al., Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease. A prospective cohort study. J. Am. Coll. Cardiol., 66 : 1538-1548 (2015)
PubMed
7) Schwingshackl L, Hoffmann G, Monounsaturated fatty acids and risk of cardiovascular disease : synopsis of evidence available from systematic reviews and meta-analysis. Nutrients, 4 : 1989-2007 (2012)
PubMed
8) Nestel P, Trans fatty acids : are its cardiovascular risks fully appreciated? Clin. Ther., 36 : 315-321 (2014)
PubMed
9) Iggman D, Rosqvist F, Larsson A et al., Role of dietary fats in modulating cardiometabolic risk during moderate weight gain : a randomized double-blind overfeeding trial (LIPOGAIN study). J. Am. Heart Assoc., 2014 Oct 15; 3 (5) :e001095
 
10) Guldbrand H, Lindstrom T, Dizdar B et al., Randomization to a low-carbohydrate diet advice improves health related quality of life compared with a low-fat diet at similar weight-loss in Type 2 diabetes mellitus. Diabetes Res. Clin. Pract., 106 : 221-227 (2014)
PubMed
11) Sanders TAB, How important is the relative balance of fat and carbohydrate as sources of energy in relation to health? Proc. Nutr. Soc., 2015 Nov 13 : 1-7
 

第9章 食用油脂の安全性を巡って

P.261 掲載の参考文献
1) MacMahon S ed., Processing Contaminants in Edible Oils : MCPD and Glycidyl Esters. AOCS Press, Urbana, Illinois (2014)
 
2) Crews C, Chiodini A, Granvogl M et al., Analytical approaches for MCPD esters and glycidyl esters in food and biological samples : a review and future prospectives. Food Addit. Contam. Part A, 30 : 11-45 (2013)
 
3) 桂木能久, グリシドール脂肪酸エステルの最近の研究. イルシー, No.112 : 3-12 (2013)
 
4) Matthaus B, Pudel F, Approaches to mitigating esters of both 3-MCPD and glycidol. Inform, 25 : 652-654, 672 (2014)
 
5) Wang Q, Imamura F, Lemaitre R et al., Plasma phospholipid trans-fatty acids levels, cardiovascular disease, and total mortality : the Cardiovascular Health Study. J. Am. Heart Assoc., 2014 ; 3 : e000914, August 27, 2014
 
6) Chowdhury R, Johnson L, Steur M, Trans fatty acid isomers in mortality and incident coronary heart disease risk. J. Am. Heart Assoc., 2014 ; 3 : e001195, August 27, 2014
 
7) 食品安全委員会, 化学物質・汚染物質専門委員会, (案) 化学物質・汚染物質評価書 加熱時に生じるアクリルアミド, 2014年5月
 
8) Arvanitoyannis IS, Dionisopoulou N, Acrylamide : formation, occurrence in food products, detection methods, and legislation. Crit. Rev. Food Sci. Nutr., 54 : 708-733 (2014)
PubMed
9) 農林水産省, 食品中のアクリルアミドを低減するための指針, 第1版. 2013年
 
10) 厚生労働省, 薬事・食品衛生審議会食品衛生分科委員会, アスパラギナーゼ (Aspergillus niger ASP-72株を用いて生産されたもの) の食品添加物の指定に関する部会報告書 (案), 2014年6月4日
 
11) Cheng J, Chen X, Zhao S et al., Antioxidant-capacity-based models for the prediction of acrylamide reduction by aavonoids. Food Chem., 168 : 90-99 (2015)
PubMed
12) EFSA Panel on Contaminants in the Food Chain (CONTAM), Draft scientific opinion on acrylamide in food, Endorsed for public consultation-draft scientific opinion. EFSA Journal 20YY ; volume (issue) : NNNN
 
13) Pelucchi C, Bosetti C, Galeone C et al., Dietary acrylamide and cancer risk : an updated metaanalysis. Int. J. Cancer, 136 : 2912-2922 (2015)
PubMed
14) Nagata C, Konishi K, Tamura T et al., Associations of acrylamide intake with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Epidemiol. Biomarkers Prev., 24 : 249-254 (2015)
PubMed
15) Obon-Santacana M, Peeters PH, Freisling H et al., Dietary intake of acrylamide and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Cancer Epidemiol. Biomarkers Prev., 24 : 291-297 (2015)
PubMed
16) Grootveld M, Ruiz-Rodado V, Silwood CJL, Detection, monitoring, and deleterious health effects of lipid oxidation products generated in culinary oils during thermal stressing episodes. Inform, 25 : 614-624 (2014)
 
17) Zribi A, Jabeur H, Aladedunye F et al., Monitoring of quality and stability characteristics and fatty acid compositions of refined olive oil and seed oils during repeated pan- and deep-frying using GC, FT-NIRS, and Chemometrics. J. Agr. Food Chem., 62 : 10357-10367 (2014)
 
18) 戸谷洋一郎監修, 油脂の特性と応用, p.19. 幸書房 (2012)
 
19) Logan A, Nienaber U, Pan X (S) eds., Lipid Oxidation : Challenges in Food Systems. AOCS Press, Urbana, Illinois (2013)
 
20) Curtis TY, Posties J, Halford NG, Reducing the potential for processing contaminant formation in cereal products. J. Cereal Sci., 59 : 382-392 (2014)
 

第10章 脂質と健康 : 新しい情報を中心に

P.276 掲載の参考文献
1) Teicholz N, The Big Fat Surprise : Why Butter, Meat & Cheese Belong in a Healthy Diet. Simon & Schuster, UK (2014)
 
2) Smith R, Are some diets "mass murder"? BMJ, 349 : g7654 (2014)
PubMed
3) Howard BV, Van Horn L, Hsia J et al., Low-fat dietary pattern and risk of cardiovascular disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA, 295 : 655-666 (2006)
PubMed
4) Hooper L, Summerbell CD, Thompson R et al., Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev., 2012 May 16 ; 5 : CD002137
 
5) O'Sullivan TA, Hafekost K, Mitrou F et al., Food sources of saturated fat and the association with mortality : a meta-analysis. Am. J. Public Health, 103 (9) : e31-e42 (2013)
PubMed
6) Santaren ID, Watkins SM, Liese AD et al., Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. Am. J. Clin. Nutr., 100 : 1532-1540 (2014)
 
7) Das UN, Nutritional factors in the prevention and management of coronary artery disease and heart failure. Nutrition, 31 : 283-291 (2015)
PubMed
8) Harcomb Z, Baker JS, Cooper SM et al., Evidence from randomized controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983 : a systematic review and metaanalysis. Open Heart, 2015 ; 2 : e000196
 
9) Sintra ST, Teter BB, Bowden J et al., The saturated fat, cholesterol, and statin controversy a commentary, J. Am. Coll. Nutr., 33 : 79-88 (2014)
 
10) Bahl R, The evidence base for fat guidelines : a balanced diet. Open Heart, 2015 ; 2 : e000229
PubMed
11) Crous-Bou M, Fung TT, Prescott J et al., Mediterranean diet and telomere length in Nurses' Health Study : population based cohort study. BMJ, 349 : g6674 (2014)
PubMed
12) Rees K, Hartley L, Flowers N et al., "Mediterranean" dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev., 2013 Aug 12 ; 8 : CD009825
PubMed
13) Schwingshackl L, Hof fmann G, Monounsaturated fatty acids, olive oil and health status : a systematic review and meta-analysis of cohort studies. Lipids Health Disease, 13 : 154 (2014)
 
14) WHO, Global status report on noncommunicable diseases 2014, "Attaining the nine global noncommunicalbe diseases targets ; a shared responsibility"
 
15) Fodor JG, Helis E, Yazdekhasti N et al., "Fishing" for the origins of the "Eskimos and heart disease" story : facts or wishful thinking? Can. J. Cardiol., 30 : 864-868 (2014)
PubMed
16) 1970s Fish oil study criticized but original author says critics twisted facts to get attention. Inform, 26 : 25-27 (2015)
 
17) Tani S, Takahashi A, Nagao K et al., Association of fish consumption-derived ratio of serum n-3 to n-6 polyunsaturated fatty acids and cardiovascular risk with the prevalence of coronary artery disease. A cross-sectional pilot study. Int. Heart J., 56 : 260-268 (2015)
 
18) Marklund M, Leander K, Vikstrom M et al., Polyunsaturated fat intake estimated by circulating biomarkers and risk of cardiovascular disease and all-cause mortality in a population-based cohort of 60-year-old men and women. Circulation, 132 : 586-594 (2015)
 
19) Sugiyama D, Okamura T, Watanabe M et al., Risk of hypercholesterolemia for cardiovascular disease and the population-attributable fraction in a 24-year Japanese cohort study. J. Atheroscler. Thromb., 22 : 95-107 (2015)
 
20) Jiao J, Li Q, Chu J et al., Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age : a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 100 : 1422-1436 (2014)
 
21) Kagan ML, Levy A, Leikin-Frenkel A, Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats. Food Funct., 6 : 185-191 (2015)
 
22) Kohler A, Sarkkinen E, Tapola N et al., Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial. Lipids Health Dis., 14 : 19 (2015)
 
23) Yurko-Mauro K, Kralovec J, Bailey-Hall E et al., Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids Health Dis., 14 : 99 (2015)
PubMed
24) Ghasemifard S, Sinclair AJ, Kaur G et al., What is the most effective way of increasing the bioavailability of dietary long chain omega-3 fatty acids-daily vs. weekly administration of fish oil? Nutrients, 7 : 5628-5645 (2015)
PubMed
25) Browning LM, Walker CG, Mander AP et al., Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans. J. Nutr., 144 : 667-672 (2014)
 
26) Ghasemifard S, Turchini GM, Sinclair AJ, Omega-3 long chain fatty acid "bioavailability" : a review of evidence and methodological considerations. Prog. Lipid Res., 56 : 92-108 (2014)
PubMed
27) Strain JJ, Yeates AJ, van Wijngaarden E et al., Prenatal exposure to methyl mercury from fish consumption and polyunsaturated fatty acids : associations with child development at 20 mo of age in an observational study in the Republic of Seychelles. Am. J. Clin. Nutr., 101 : 530-537 (2015)
 
28) EFSA Scientific Committee, Statement on the benefits of fish/seafood consumption compared to the risk of methylmercury in fish/seafood. EFSA J., 13 (1) : 3982 (2015)
 
29) Drevnick PE, Lamborg CH, Horgan MJ, Increase in mercury in pacific yellowfin tuna. Environ. Toxicol. Chem., 34 : 931-934 (2015)
PubMed
30) Walker TB, Parker MJ, Lessons from the war on dietary fat. J. Am. Coll. Nutr., 33 : 347-351 (2014)
PubMed
31) Hooper L, Abdelhamid A, Moore HJ et al., Effect of reducing total fat intake on body weight : systematic review and meta-analysis of randomized controlled trials and cohort studies. BMJ, 345 : e7666 (2012)
PubMed
32) Noto H, Goto A, Tsujimoto T et al., Low-carbohydrate diets and all-cause mortality : a systematic review and meta-analysis of observational studies. PLoS ONE, 8 (1) : e55030 (2013)
PubMed
33) Bazzano LA, Hu T, Reynolds K et al., Effects of low-carbohydrate and low-fat diets : a randomized trial. Ann. Intern. Med., 161 : 309-318 (2014)
PubMed
34) Sacks FM, Carey VJ, Anderson CAM et al., Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity. The OmniCarb Randomized Clinical Trial. JAMA, 312 : 2531-2541 (2014)
PubMed
35) Wu H, Flint AJ, Qi Q et al., Association between dietary whole grain intake and risk of mortality : two large prospective studies in US men and women. JAMA Intern. Med., 175 : 373-384 (2015)
PubMed
36) Qi Q, Chu AY, Kang J et al., Fried food consumption, genetic risk, and body mass index : gene-diet interaction analysis in three US cohort studies. BMJ, 348 : g1610 (2014)
PubMed
37) 徳永勝人, 古林孝保, 肥満・肥満症の予防と治療, 食事療法. 日本臨床, 71 : 315-319 (2013)
Medical*Online
38) Scientific opinion on the essential composition of total diet replacements for weight control. EFSA J., 13 (1) : 3957 (2015)
 
39) Lamarche B, Couture P, Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr. Opin. Lipidol., 26 : 42-47 (2015)
PubMed
40) Ooi EMM, Watts GF, Ng TWK et al., Effect of dietary fatty acids on human lipoprotein metabolism : a comprehensive update. Nutrients, 7 : 4416-4425 (2015)
PubMed
41) Yanai H, Katsuyama H, Hamasaki H et al., Effects of dietary fat intake on HDL metabolism. J. Clin. Med. Res., 7 : 145-149 (2015)
PubMed
42) Pikula A, Beiser AS, Wang J et al., Lipid and lipoprotein measurements and the risk of ischemic vascular events. Framingham Study. Neurology, 84 : 472-479 (2015)
PubMed
43) Verdoia M, Schaf fer A, Sur yapranata H et al., Effect of HDL-modifiers on cardiovascular outcomes : a meta-analysis of randomized trials. Nutr. Metab. Cardiovasc. Dis., 25 : 9-23 (2015)
 
44) Navar-Boggan AM, Peterson ED, D'Agostino RB et al., Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation, 131 : 451-458 (2015)
PubMed
45) USDA, Scientific Report of the 2015 Dietary Guidelines Advisory Committee. February 2015, http://www.health.gov/dietaryguidelines
 
46) Orsavova J, Misurcova L, Ambrozova JV et al., Fatty acids composition of vegetable oils and its contribution to dietary energy intake and dependence of cardiovascular mortality on dietary intake of fatty acids. Int. J. Mol. Sci., 16 : 12871-12890 (2015)
PubMed
47) Harika RK, Eilander A, Alssema M et al., Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease : a systematic review of data from 40 countries. Ann. Nutr. Metab., 63 : 229-238 (2013)
 
48) Shen W, Gaskins HR, McIntosh MK, Inauence of dietary fat on intestinal microbes, inaammation, barrier function and metabolic outcomes. J. Nutr. Biochem., 25 : 270-280 (2015)
 
49) Ettinger R, MacDonald K, Reid G et al., The inauence of the human microbiome and probiotics on cardiovascular health. Gut Microbes, 5 : 719-726 (2014)
 
50) Miyamoto J, Mizukure T, Park S-B et al., A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR 40-MEK-ERK pathway. J. Biol. Chem., 290 : 2902-2918 (2015)
PubMed
51) Chassaing B, Koren O, Goodrich JK et al., Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature, 519 : 92-96 (2015)
PubMed
52) Calder PC, Functional roles of fatty acids and their effects on human health. J. Parenter. Enteral. Nutr., 39 (1 Suppl) : 18S-32S (2015)
 
53) Poudyal H, Brown L, Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function? Prog. Lipid Res., 59 : 172-200 (2015)
PubMed
54) Locke AE, Kahali B, Berndt SI et al., Geneteic studies of body mass index yield new insights for obesity biology. Nature, 518 : 197-206 (2015)
 
55) Ard J, Obesity in the US : what is the best role for primary care? BMJ, 350 : g7846 (2015)
PubMed
56) Carson TL, Hidalgo B, Ard JD et al., Dietary interventions and quality of life : a systematic review of the literature. J. Nutr. Educ. Behav., 46 : 90-101 (2014)
PubMed
57) Northup T, Understanding the relationship between television use and unhealthy eating : the mediating role of fatalistic views of eating well and nutritional knowledge. Int. J. Commun. Health, 2014/No.3 : 10-15
 

書評

最近チェックした商品履歴

Loading...